Download the official Katrien Lagrou Michael Netea Andreas Groll … · 2018-06-27 · Andreas...
Transcript of Download the official Katrien Lagrou Michael Netea Andreas Groll … · 2018-06-27 · Andreas...
RAI Congress Center, Amsterdam, The Netherlands
30 June - 4 July 2018
20th Congress of the International Society for Human and Animal Mycology (ISHAM)
www.isham2018.org
Program
www.isham2018.org
Regional scientific committeeAndreas GrollBart-Jan KullbergBas ZwaanEd KuijperFrank van de VeerdonkHan WöstenJohan MaertensJohan Mouton
Katrien LagrouMichael NeteaOliver CornelyPedro CrousPeter-Michael RathPieter Jan HaasTeun BoekhoutWendy van de Sande
Download the official ISHAM2018 APP
Do not forget to use #ISHAM2018 when posting photos and comments of the event on your social networks.
International scientific committeeAhmed Fahal Alexandro BonifazAna Alastruey-IzquierdoAndreas Groll, MunsterAndrew Ullman, WurzburgAnuradha ChowdharyArnaldo ColomboArturo CasadevallArunaloke Chakrabarti Ashraf IbrahimAxel BrakhageBernhard HubeBill SteinbachBirgit WillingerChristophe d’EnfertCornelia Lass-FloerlCornelius ClancyDarius Armstrong JonesDavid AndesDavid Denning David PerlinDimitrios KontoyiannisDonald SheppardDonna MacCallumElizabeth JohnsonEmanuel Roilides Eric DannaouiFlavio Queiros TellesGordon Brown
Hamid BadaliHan LiHideoki OgawaJean-Pierre Gangneux Jesus GuineaJoe HeitmanJoerg SteinmannJohan MaertensJosef Guarro, Josef MeletiadisKatrien LagrouLewis White, Livio PaganoLuis Ostrosky-Zeichner Mahmoud Ghannoum Maiken Arendrup Malcolm RichardsonManuel Cuenca, Marcus TeixeraMartin HoeniglMartin SchallerMatteo BasettiMatthew FisherMaurizio SanguinettiMichaela LacknerNathan Wiederhold Neil GowNelish GovenderNicolai Klimko
Nina Gunde-Cimerman Oliver CornelyOliver Kurzai Olivier LortholaryPatrice le PapePeter PappasPeter-Michael RathRetno WahyuningsihRoxana VitaleRuo-yu Li, Beijing, China Russel Edward Ruth AshbeeRyoji TsuboiSean Zhang,Sevtap Arikan Sharon Chen Shawn LockhartStephane BretagneStephane Ranque Thomas WalshTom Chiller, Tom PattersonTom RogersWanqing LiaoWei-da LiuWieland MeyerYee-Chun Chen
INTR
OD
UCT
ION INTRODUCTION
Dear Colleagues and Friends,
It is our great pleasure to extend a warm welcome to all of you to the Netherlands and to the 20th Congress of the International Society for Human and Animal Mycology (ISHAM).
ISHAM 2018 aims to provide clinicians, scientists and students an exciting opportunity to meet at an international forum dedicated solely to the study of medical mycology. Many colleagues from all over the world will be joining us including many young scientists and students. We are proud to host such an important meeting in our country. The Netherlands has a strong track record in mycology with leading scientists at the Center of Expertise in Mycology RadboudUMC/CWZ in Nijmegen, the Westerdijk Fungal Biodiversity Institute (former CBS) in Utrecht, and many others.
Together with the scientific committee, we have done our best to put together a strong and attractive scientific program spanning all hot topics in basic, translational and clinical mycology. We hope that you will find the meeting rewarding and that you will enjoy your stay in our capital city, Amsterdam, which is a place of many inspiring and surprising faces. No other city mixes cosmopolitan style and relaxed atmosphere quite like Amsterdam where our hospitable nature attracts an excitingly diverse population.
We wish you an enriching congress and an excellent stay in Amsterdam.
The organizing committee Paul E. Verweij, Congress President Ferry Hagen, TreasurerJacques F. Meis, Vice-president Sybren de Hoog, Chair Scientific Committee
Dear Delegates,
The ISHAM Congress fulfils our mission of education and sharing the latest research and discussion across a wide spectrum of topics in medical mycology. This Congress will be no exception. I welcome all of you and hope that this Congress will serve as a catalyst for strengthening international collaboration. On behalf of the ISHAM council I would like to thank everyone who has been involved in organising this event, and our industrial partners.
Best wishes, Malcolm RichardsonISHAM President
Saturday 30 June 201808:30 - 15:30 Young ISHAM symposium12:30 Registration Open16:00 - 17:30 Opening ceremony17:30 - 19:00 Welcome reception
Sunday 1 July 2018 Fundamental Clinical Translational Special Interest Working Groups
08:00 - 09:00 Forum General Assembly ISHAM09:00 - 10:00 Forum Plenary session I10:00 - 10:30 Break10:30 - 12:00
Parallel session I
E103 S1.1 Basic mechanisms of antifungal immunity
Forum S1.2 Mycotic keratitis
E102 S1.3 The Mycobiome in Health and Disease
E104 S1.4 Chromoblastomycosis: the role of immunity
E107 S1.5 EFISG/ECMM Aspergillus guidelines
E108 S1.6 ISHAM Working Group: Genotyping of Cryptococcus
12:00 - 13:30 Lunch break 12:15 - 13:15 Ruby lounge Poster Pitch session I12:30 - 13:30 Forum Sponsored symposium13:30 - 14:30 Forum Plenary session II14:30 - 15:00 Break15:00 - 16:30 Parallel session II E103
S2.1 Nutrition and stress
Forum S2.2 Candida auris
E102 S2.3 Antifungal stewardship
E104 S2.4 Global epidemiology & One Health of Aspergillus fumigatus
E107 S2.5 CLSI & EUCAST
E108 S2.6 ISHAM Working Group: Medical Phycology
16:30 - 18:00 Parallel session III E103 S3.1 Evolutionary strategies of fungal pathogens
Forum S3.2 AIDS-related mycoses
E102 S3.3 Indoor fungi and sick buildings
E104 S3.4 ISHAM Working Group: Veterinary Mycology
E107 S3.5 Pneumocystis
E108 S3.6 Late breakers
E105 S3.7 Behind the scene of scientific publising
18:00 - 19:00 Ruby Lounge Poster Pitch session II
Monday 2 July 2018 09:00 - 10:00 Forum Plenary session III10:00 - 10:30 Break10:30 - 12:00 Parallel sessions IV E103
S4.1 Molecular and cell biology of fungal pathogens
Forum S4.2 Cryptococcal meningitis clinical trials
E102 S4.3 Antifungals Pipeline session
E104 S4.4 Invasive infections in Asia
E107 S4.5 New insights in the management of invasive fungal disease in haematology
E108 S4.6 MMCR case report session
12:00 - 13:30 Lunch Break 12:15 - 13:15 Ruby Lounge Poster Pitch session III13:30 - 14:30 Forum Plenary session IV14:30 - 15:00 Break15:00 - 16:30 Parallel session V E103
S5.1 Hot topics in Taxonomy – Can we define fungal species borders?
Forum S5.2 Superficial dermatophytes
E102 S5.3 Beyond antifungal / host directed therapy
E104 S5.4 Mucoralean infections
E107 S5.5 From Basic Science to Patient Care
E108 S5.6 ISHAM Working Group: Fusarium
16:30 - 18:00 Parallel session VI E103 S6.1 Functional genomics and systems biology
Forum S6.2 ABPA
E102 S6.3 Tropical implantation diseases
E104 S6.4 Aspergillus terreus frontline
E107 S6.5 Malassezia in humans and animals
E108 S6.6 Surveillance azole resistance
18:00 - 20:00 Ruby Lounge Poster Pitch session IV19:00 Young ISHAM Beachparty
Tuesday 3 July 2018 09:00 - 10:00 Forum Plenary session V10:00 - 10:30 Break10:30 - 12:00 Parallel session VII E103
S7.1 Fungal biofilms Forum S7.3 The Real Pathogens: Ajellomycetaceae
E102 S7.4 Why do patients get aspergillosis?
E104 S7.5 Scedosporium
E107 S7.6 ISHAM Working Group: Sporothrix
E108 S7.7 Pediatrics
E106 S7.2 Fungal Interactions with Epithelium Trigger Innate Immune Activation
12.00 - 13.30 Lunch break12:15 - 13:00 Ruby Lounge Poster Pitch session V13:30 - 14:30 Forum Plenary session VI14:30 - 15:00 Break15:00 - 16:30 Parallel session VIII E103
S8.1 Host-pathogen interactions - the pathogen perspective
Forum S8.3 Management of fungal resistance
E102 S8.4 DNA Barcoding
E104 S8.5 Challenges in mucosal and invasive candidiasis
E107 S8.6 ECMM Educational Symposium
E108 S8.7 New developments in dermatomycosis
E106 S8.2 Milestones in medical mycology: history in modern light
16:30 - 18.00 Parallel sessions IX E103 S9.1 Genotyping in the NGS era
Forum S9.3 Dosing antifungal from the XXS to XXXL
E102 S9.4 MALDI-TOF in filamentous fungi
E104 S9.5 Recent advances in diagnosing aspergillosis
E108 S9.7 Cryptococcus-host interactions
E106 S9.2 Developments in Chinese medical mycology
18:00 Congress Dinner
Wednesday 4 July 2018 09:00 - 10:00 Forum Plenary session VII10:00 - 10:30 Break10:30 - 12:00 Parallel session X E103
S10.1 The technical revolutions ahead of us NGS, proteomics, Crispr-cas
Forum S10.3 ISHAM-EFISGsymposium: From non-responder to fungal breakthrough infections by opportunistic yeasts and molds
E102 S10.4 Ecology and outbreaks
E104 S10.5 Closing the mycetoma knowledge gap
E107 S10.6 Fungal respiratory infections in Cystic Fibrosis
E108 S10.7 Candida auris
E106 S10.2 ISHAM Working Group: Fungal PCR Initiative
12.00 - 12.30 Forum Closing ceremony
Prog
ram
me
at a
gla
nce
Index
· Introduction Scientific program 1
· Program
Saturday 30 June 2018 4
Sunday 1 July 2018 9
Monday 2 July 2018 19
Tuesday 3 July 2018 27
Wednesday 4 July 2018 37
· E-Posters & Poster Pitch Presentations 42
· Social Program 64
· General information 68
· Sponsored integrated symposia 70
· Sponsors and exhibitors 71
· Floorplan 72
INTRODUCTION TO THE SCIENTIFIC PROGRAMPlenary sessionsNo session will be held in parallel to these sessions.Plenary sessions are indicated by the prefix: PS Parallel sessionsThese sessions are composed by conveners on specific topics to be recognized on different colors:- Fundamental: green - Clinical: red- Translational: pink- Special interest working groups: blue
Parallel sessions are indicated by the prefix: S
1
INTR
OD
UCT
ION INTRODUCTION
Dear Colleagues and Friends,
It is our great pleasure to extend a warm welcome to all of you to the Netherlands and to the 20th Congress of the International Society for Human and Animal Mycology (ISHAM).
ISHAM 2018 aims to provide clinicians, scientists and students an exciting opportunity to meet at an international forum dedicated solely to the study of medical mycology. Many colleagues from all over the world will be joining us including many young scientists and students. We are proud to host such an important meeting in our country. The Netherlands has a strong track record in mycology with leading scientists at the Center of Expertise in Mycology RadboudUMC/CWZ in Nijmegen, the Westerdijk Fungal Biodiversity Institute (former CBS) in Utrecht, and many others.
Together with the scientific committee, we have done our best to put together a strong and attractive scientific program spanning all hot topics in basic, translational and clinical mycology. We hope that you will find the meeting rewarding and that you will enjoy your stay in our capital city, Amsterdam, which is a place of many inspiring and surprising faces. No other city mixes cosmopolitan style and relaxed atmosphere quite like Amsterdam where our hospitable nature attracts an excitingly diverse population.
We wish you an enriching congress and an excellent stay in Amsterdam.
The organizing committee Paul E. Verweij, Congress President Ferry Hagen, TreasurerJacques F. Meis, Vice-president Sybren de Hoog, Chair Scientific Committee
Dear Delegates,
The ISHAM Congress fulfils our mission of education and sharing the latest research and discussion across a wide spectrum of topics in medical mycology. This Congress will be no exception. I welcome all of you and hope that this Congress will serve as a catalyst for strengthening international collaboration. On behalf of the ISHAM council I would like to thank everyone who has been involved in organising this event, and our industrial partners.
Best wishes, Malcolm RichardsonISHAM President
Saturday 30 June 201808:30 - 15:30 Young ISHAM symposium12:30 Registration Open16:00 - 17:30 Opening ceremony17:30 - 19:00 Welcome reception
Sunday 1 July 2018 Fundamental Clinical Translational Special Interest Working Groups
08:00 - 09:00 Forum General Assembly ISHAM09:00 - 10:00 Forum Plenary session I10:00 - 10:30 Break10:30 - 12:00
Parallel session I
E103 S1.1 Basic mechanisms of antifungal immunity
Forum S1.2 Mycotic keratitis
E102 S1.3 The Mycobiome in Health and Disease
E104 S1.4 Chromoblastomycosis: the role of immunity
E107 S1.5 EFISG/ECMM Aspergillus guidelines
E108 S1.6 ISHAM Working Group: Genotyping of Cryptococcus
12:00 - 13:30 Lunch break 12:15 - 13:15 Ruby lounge Poster Pitch session I12:30 - 13:30 Forum Sponsored symposium13:30 - 14:30 Forum Plenary session II14:30 - 15:00 Break15:00 - 16:30 Parallel session II E103
S2.1 Nutrition and stress
Forum S2.2 Candida auris
E102 S2.3 Antifungal stewardship
E104 S2.4 Global epidemiology & One Health of Aspergillus fumigatus
E107 S2.5 CLSI & EUCAST
E108 S2.6 ISHAM Working Group: Medical Phycology
16:30 - 18:00 Parallel session III E103 S3.1 Evolutionary strategies of fungal pathogens
Forum S3.2 AIDS-related mycoses
E102 S3.3 Indoor fungi and sick buildings
E104 S3.4 ISHAM Working Group: Veterinary Mycology
E107 S3.5 Pneumocystis
E108 S3.6 Late breakers
E105 S3.7 Behind the scene of scientific publising
18:00 - 19:00 Ruby Lounge Poster Pitch session II
Monday 2 July 2018 09:00 - 10:00 Forum Plenary session III10:00 - 10:30 Break10:30 - 12:00 Parallel sessions IV E103
S4.1 Molecular and cell biology of fungal pathogens
Forum S4.2 Cryptococcal meningitis clinical trials
E102 S4.3 Antifungals Pipeline session
E104 S4.4 Invasive infections in Asia
E107 S4.5 New insights in the management of invasive fungal disease in haematology
E108 S4.6 MMCR case report session
12:00 - 13:30 Lunch Break 12:15 - 13:15 Ruby Lounge Poster Pitch session III13:30 - 14:30 Forum Plenary session IV14:30 - 15:00 Break15:00 - 16:30 Parallel session V E103
S5.1 Hot topics in Taxonomy – Can we define fungal species borders?
Forum S5.2 Superficial dermatophytes
E102 S5.3 Beyond antifungal / host directed therapy
E104 S5.4 Mucoralean infections
E107 S5.5 From Basic Science to Patient Care
E108 S5.6 ISHAM Working Group: Fusarium
16:30 - 18:00 Parallel session VI E103 S6.1 Functional genomics and systems biology
Forum S6.2 ABPA
E102 S6.3 Tropical implantation diseases
E104 S6.4 Aspergillus terreus frontline
E107 S6.5 Malassezia in humans and animals
E108 S6.6 Surveillance azole resistance
18:00 - 20:00 Ruby Lounge Poster Pitch session IV19:00 Young ISHAM Beachparty
Tuesday 3 July 2018 09:00 - 10:00 Forum Plenary session V10:00 - 10:30 Break10:30 - 12:00 Parallel session VII E103
S7.1 Fungal biofilms Forum S7.3 The Real Pathogens: Ajellomycetaceae
E102 S7.4 Why do patients get aspergillosis?
E104 S7.5 Scedosporium
E107 S7.6 ISHAM Working Group: Sporothrix
E108 S7.7 Pediatrics
E106 S7.2 Fungal Interactions with Epithelium Trigger Innate Immune Activation
12.00 - 13.30 Lunch break12:15 - 13:00 Ruby Lounge Poster Pitch session V13:30 - 14:30 Forum Plenary session VI14:30 - 15:00 Break15:00 - 16:30 Parallel session VIII E103
S8.1 Host-pathogen interactions - the pathogen perspective
Forum S8.3 Management of fungal resistance
E102 S8.4 DNA Barcoding
E104 S8.5 Challenges in mucosal and invasive candidiasis
E107 S8.6 ECMM Educational Symposium
E108 S8.7 New developments in dermatomycosis
E106 S8.2 Milestones in medical mycology: history in modern light
16:30 - 18.00 Parallel sessions IX E103 S9.1 Genotyping in the NGS era
Forum S9.3 Dosing antifungal from the XXS to XXXL
E102 S9.4 MALDI-TOF in filamentous fungi
E104 S9.5 Recent advances in diagnosing aspergillosis
E108 S9.7 Cryptococcus-host interactions
E106 S9.2 Developments in Chinese medical mycology
18:00 Congress Dinner
Wednesday 4 July 2018 09:00 - 10:00 Forum Plenary session VII10:00 - 10:30 Break10:30 - 12:00 Parallel session X E103
S10.1 The technical revolutions ahead of us NGS, proteomics, Crispr-cas
Forum S10.3 ISHAM-EFISGsymposium: From non-responder to fungal breakthrough infections by opportunistic yeasts and molds
E102 S10.4 Ecology and outbreaks
E104 S10.5 Closing the mycetoma knowledge gap
E107 S10.6 Fungal respiratory infections in Cystic Fibrosis
E108 S10.7 Candida auris
E106 S10.2 ISHAM Working Group: Fungal PCR Initiative
12.00 - 12.30 Forum Closing ceremony
Prog
ram
me
at a
gla
nce
2 3
SATURDAY 30 JUNE 2018
E-Posters & Poster Pitch SessionsPosters are submitted electronically and can be retrieved as electronic posters (e-posters) on poster terminals that will be available during the entire congress. Posters and abstracts can be found in the congress App and in the digital abstract supplement of the journal Medical Mycology, see www.ISHAM2018.org The Poster Pitch Sessions will be held at the poster terminals in the Ruby Lounge.Selected posters will be discussed during the Poster Pitch Sessions. These sessions will have a specific common thematic focus and therefore will give you the opportunity to meet colleagues from other countries working in the same field of interest. The sessions will be guided by experts in the field. After the session there will be opportunity for further discussion. Sunday 1 July 12:15 - 13:15 hrs. Sunday 1 July 18:00 - 19:00 hrs. Monday 2 July 12:15 - 13:15 hrs.Monday 2 July 18:00 - 19:00 hrs.Tuesday 3 July 12:15 - 13:15 hrs.
Information for speakersThe meeting rooms are equipped with a data projector. Please bring your presentation onmemory stick to Speaker Slide Center room E001 latest in the break before the start of your session. Technicians will assist you loading your presentation. It is not allowed to useyour own laptop. Please make sure your presentation is suitable for Microsoft PC (noMacintosh). The conference program is very tight, with not much free time betweensessions. Please respect the allotted time for presentation to ensure that your sessionstays on track. Arrive at the meeting room ten minutes before the session starts. Becomefamiliar with the operation of the audiovisual equipment. Greet the chairs who willexplain how they would like to run the session. Information for session chairs / convenersThank you for accepting to chair a session. Your contribution is veryimportant to ensure that sessions run smoothly, and to stimulate discussion.The conference program is very tight, with not much free time between sessions.Part of your contribution as a chair will be to ensure that your session stays on track.We kindly ask you to arrive in the room ten minutes before the session starts tobecome familiar with the operation of the audiovisual equipment. Please explain to thepresenters how you would like to run the session. The presenters are asked to bringtheir presentation on memory stick to the speaker slide center, latest in the breakbefore the start of the session. Technicians will assist chairs and presenters inthe meeting room. It is not allowed to use own laptops.
SATU
RDAY
Saturday 30 June 2018
Young ISHAM symposium
09:00 – 15:30 Young ISHAM symposium Forum
09:00 Opening Ferry Hagen, the Netherlands & Marcus Teixeira, USA
09:10 Lecture senior scientist Chair: Marcus Teixeira, USA Speaker: John Rex, United Kingdom
09:50 – 11:00 Young ISHAM presentations Chair: Ferry Hagen, the Netherlands
09:50 Newest Kid on the Block: Characterization of the novel multidrug-resistant pathogen, Candida auris
Tejas Bouklas, USA09:58 Chromoblastomycosis and sporotrichosis in Madagascar: an
update on epidemiology, clinical presentation and molecular diagnosis
Tahinamandranto Rasamoelina, Madagascar10:06 Recognition of DHN-melanin by the C-type lectin, MelLec, is
required for protective immunity to Aspergillus fumigatus Mark Stappers, United Kingdom10:14 Using Whole-Genome Sequencing to Identify Recent Introductions
and Track the Spread of Candida auris in the United States Nancy Chow, USA10:22 Genomic perspective of triazole resistance in Aspergillus
fumigatus| isolates without cyp51A mutations using Whole-Genome Sequencing
Cheshta Sharma, India10:30 The mitochondria-associated J-domain protein Dnj1 is required
for virulence in the fungal pathogen Cryptococcus neoformans Linda Horianopoulos, Canada
10:40 – 11:00 Coffee break Forum & Ruby Lounge
11:00 – 11:45 The benefits of scientific mobility and international collaboration
Chair: Marcus Teixeira, USA Speakers: Radamés Cordero, USA
11:45 – 12:45 Young ISHAM presentations Chairs: Ana Alastruey-Izquierdo, Spain & Leonardo Nimrichter, Brazil
11:30 Generation and characterization of Candida parapsilosis over expression mutant strains
Sara Pál, Hungary11:38 The vacuolar sorting protein Vps45 links iron uptake,
mitochondrial function and virulence in the pathogenic fungus Cryptococcus neoformans
Mélissa Caza, Canada11:46 Novel FK506 analog exhibits anti-fungal activity against
Cryptococcus neoformans in vitro and in an animal model Michael Hoy, USA11:54 New insights into the Cryptococcus neoformans capsule structure Radamés Cordero, USA12:02 Pantothenic acid improves culturability of dormant Cryptococcus
neoformans Benjamin Hommel, France12:10 Magnetic resonance imaging of infected mouse brains allows
non- invasive screening of differences in the virulence of clinical Cryptococcus neoformans strains
Liesbeth Vanherp, Belgium12:18 Whole genome sequencing of P. brasiliensis isolates of endemic
areas in Argentina and Paraguay Maria Cattana, Argentina
12:26 – 13:15 LunchForum & Ruby Lounge
54
SATU
RDAY
6
ISHAM CONGRESS
16:00 WelcomeForum & Local Organising Committee Ruby Lounge Paul E. Verweij, Congress President
16.15 Welcome from the President of ISHAM and ISHAM Awards: Malcolm Richardson, ISHAM President Lucille George Award
Jack Edwards (Clinical) David Ellis (Basic Science)
ISHAM Young Investigator Awards: The fungi on sinonasal mucosa: normal content or silent threat? Aleksandra Barac, Belgrade, Serbia (Clinical) Counteracting nutritional immunity – micronutrient scavenging by human
fungal pathogens Duncan Wilson, Aberdeen, United Kingdom (Basic Science)
16:35 Opening lecture - Biodesign: From Inspiration to Integration Rosa Kieft, the Netherlands
17:30 – 19:00 Welcome receptionForum & Ruby Lounge
19:00 – 21:00 ISHAM/ECMM/GAFFI Outreach Evening Latin America and E106 South USA This evening program is only accessible for invited delegates
13:15 – 14:45 Young ISHAM presentations Chairs: Ferry Hagen, the Netherlands & Giuseppe Ianiri, USA
13:15 A prospective multi-centre study on mucormycosis in India: epidemiology, diagnosis and treatment
Hariprasath Prakash, India13:23 Eradication of fungi from sinuses helps in improvement of lower
respiratory tract’s clinical symptoms in children with cystic fibrosis Aleksandra Barac, Serbia
13:31 Mycobiome of Bondi Beach Sand Terre Darcii, Australia13:39 Evaluation of a Histoplasma antigen Lateral Flow Assay for the
rapid diagnosis of progressive disseminated histoplasmosis in Persons Living with HIV and aids
Diego Caceres, USA13:47 Alternative mechanisms of protection of Aspergillus fumigatus
conidia against Reactive Oxygen Species Esther Keizer, the Netherlands13:55 Cryptococcal meningitis is associated with vitamin D deficiency in
HIV-infected Zimbabwean adults Tinashe Nyazika, Malawi14:03 A new receptor is involved in the uptake of Sporothrix spp.
by human macrophages Gabriela Neves, Brazil14:11 Establishment and optimization of a combined MLST scheme
for Pneumocystis jirovecii Lana Pasic, Australia14:19 Orchestration of chitin synthesis at the septation site of Candida
albicans Maria Spyrou, United Kingdom
14:30 – 15:15 Lecture senior scientist Chair: Marcus Teixeira, USA Speakers: Karl Clemons, USA & Peter Donnelly, the Netherlands
15:15 – 15:30 The Dr. Ira. F. Salkin Memorial Award + Closure Karl Clemons, USA & Marcus Teixeira, USA
7
SUNDAY 1 JULY 2018
8
Sunday 1 July 2018
08:00 - 09:00 General Assembly ISHAMForum
09:00 - 10:00 PS1 Presidential address Forum Chair: Malcolm Richardson, United Kingdom Arunaloke Chakrabarti, India
10:00 - 10:30 Coffee break Forum & Ruby lounge
10:30 - 12:00 Parallel session I
S1.1 Basic mechanisms of antifungal immunityE103 Convener: Mihalis Lionakis, USA
10:30 S1.1a Basic mechanisms of antifungal immunity Mihalis Lionakis, USA10:55 S1.1b Protection and pathology in pulmonary aspergillosis Luigina Romani, Italy11:20 S1.1c Protective immune responses during cryptococcosis Carolina Coelho, USA11:45 S1.1d Evolution of Candida albicans colonization and anti-Candida
innate and adaptive immunity in patients having undergone surgical resection for Crohn’s disease
Daniel Poulain, France
S1.2 Mycotic keratitisForum Convener: Lalitha Prajna, India
10:30 S1.2a Update and epidemiology of mycotic infections of the eye Lalitha Prajna, India10:55 S1.2b Molecular characterization, diagnosis and antifungal susceptibility
patterns of clinically relevant Fusarium species Abdullah Al-Hatmi, Oman11:20 S1.2c Two Aspergillus species, A. flavus and A. fumigatus –
a comparative study of their conidial surface properties and immunological reactivities
Vishukumar Aimanianda, France11:45 S1.2d Fungal keratitis in The Netherlands Claudy Oliveira dos Santos, the Netherlands
9
10
11:20 S1.5c Children are not small adults: Management of invasive aspergillosis in pediatric patients
Andreas Groll, Germany11:45 S1.5d How to properly diagnose invasive aspergillosis? /
Recommendations on mycologic diagnosis of invasive aspergillosis
Cornelia Lass-Flörl, Austria
S1.6 ISHAM Working Group: Genotyping of Cryptococcus E108 Convener: Massimo Cogliati, Italy
10:30 S1.6a Cryptococcus neoformans and C. gattii species complex genotypes in China
Meng Xiao, China 10:55 S1.6b Genotypes of Cryptococcus neoformans and C. gattii species
complex in Europe Massimo Cogliati, Italy11:20 S1.6c Molecular epidemiology of Cryptococcus in South Africa Serisha Naicker, South Africa11:45 S1.6d Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in Latin America Carolina Firacative, Colombia
12:00 - 13:30 Lunch breakForum & Ruby Lounge
12:15 – 13:15 Poster Pitch session I Ruby Lounge View the full program on page 42
12:30 – 13:30 Sponsored symposium Forum Please see page 70 for more information about the program.
13:30 – 14:30 PS2 WHO is afraid of fungus Forum Chair: Jacques Meis, the Netherlands Carmem Pessoa Silva, Switzerland
14:30 – 15:00 Coffee breakForum & Ruby Lounge
11
SUN
DAY
S1.3 The Mycobiome in Health and Disease E102 Convener: Mahmoud Ghannoum, USA
10:30 S1.3a Mycobiome and Bacteriome Interactions: vital key of health and disease
Mahmoud Ghannoum, USA10:55 S1.3b Fungal feelings in the Irritable Bowel Syndrome René van den Wijngaard, the Netherlands11:20 S1.3c The Mycobiota: Interactions between Commensal Fungi and the
Host David Underhill, USA11:45 S1.3d Gastrointestinal microbiota alteration Induced by Mucor
circinelloides in a murine model Soo Chan Lee, USA S1.4 Chromoblastomycosis: the role of immunityE104 Convener: Peiying Feng, China
10:30 S1.4a Development of immunomodulators as adjuvant in treatment of experimental chromoblastomycosis caused by Fonseca pedrosoi
Anamelia Bocca, Brazil10:55 S1.4b Transformation into muriform cells links to refractory murine
chromoblastomycosis due to F. pedrosoi involving a chitin-induced impairment of IFN-gamma production
Bilin Dong, China11:20 S1.4c MelLec: A new receptor for melanised fungi Gordon Brown, United Kingdom11:45 S1.4d Chromoblastomycosis and sporotrichosis in Madagascar: an
update on epidemiology, clinical presentation and molecular diagnosis
Tahinamandranto Rasamoelina, Madagascar
S1.5 EFISG/ECMM Aspergillus guidelinesE107 Conveners: Sevtap Arikan, Turkey & Oliver Cornely, Germany
10:30 S1.5a Guidance in times of antifungal resistance / Current perspective for antifungal resistance in aspergillosis
Paul Verweij, the Netherlands10:55 S1.5b Chronic pulmonary aspergillosis – Focus on differences between
EU and US guidelines / Clinical guidelines for chronic pulmonary aspergillosis
David Denning, United Kingdom
SUN
DAY
12
S2.4 Global epidemiology & One Health of Aspergillus fumigatusE104 Conveners: Paul Verweij, the Netherlands & Katrien Lagrou, Belgium
15:00 S2.4a Triazole resistance mechanisms in A. fumigatus: what do we learn from full genome sequencing
Matthew Fisher, United Kingdom15:25 S2.4b Evolving epidemiology and spread of azole resistance in A. fumigatus Eveline Snelders, the Netherlands15:50 S2.4c Role of agricultural pesticide use in the evolution of triazole
resistance in fungi Bart Fraaije, United Kingdom16:15 S2.4d Azole resistance in Aspergillus fumigatus: Screening in Cystic
Fibrosis patients Steffi Rocchi, France
S2.5 CLSI & EUCASTE107 Convener: Maiken Arendrup, Denmark
15:00 S2.5a Methods for mould testing for everyone or for special ones? Joseph Meletiadis, Greece15:25 S2.5b Absorbance, turbidity, diameter, Oh my! Harmonizing disparate
yeast testing methodologies Shawn Lockhart, USA15:50 S2.5c Susceptibility testing of dermatophytes, why and how? Mahmoud Ghannoum, USA16:15 S2.5d EUCAST susceptibility testing of Trichophyton rubrum:
chloramphenicol and cycleheximide supplemented growth medium improve assay performance
Maiken Arendrup, Denmark
S2.6 ISHAM Working Group: Medical PhycologyE108 Convener: Koichi Makimura, Japan
15:00 S2.6a Microsporidiosis and pythiosis in Medical Field Koichi Makimura, Japan15:25 S2.6b Genetic and biological insights from whole-genome sequencing
of the pathogenic microalga Prototheca wickerhamii Tomasz Jagielski, Poland15:50 S2.6c Prototheca infection in dogs and cats Patrizia Danesi, Italy16:15 S2.6d Characterization of CYP51 gene of pathogenic algae of
Prototheca spp. Michiaki Masuda, Japan
13
15:00 - 16:30 Parallel session II
S2.1 Nutrition and stressE103 Convener: Alistair Brown, United Kingdom
15:00 S2.1a Carbon metabolism, immune suppression, and virulence in Candida albicans
Slavena Vylkova, Germany15:25 S2.1b Adaptation to complex host niches by fungal pathogen
C. albicans drives resistance against neutrophil attack Constantin Urban, Sweden15:50 S2.1c Nutrient sensing and Cryptococcal virulence James Kronstad, Canada16:15 S2.1d Fungal Transformers: Tracking a Moving Target Delma Childers, United Kingdom
S2.2 Candida aurisForum Convener: Ana Alastruey-Izquierdo, Spain
15:00 S2.2a Identification and antifungal susceptibility of Candida auris Anuradha Chowdhary, India15:25 S2.2b Management of Candida auris outbreaks at a national level Silke Schelenz, United Kingdom 15:50 S2.2c Global Epidemiology and strategies to control the emergence of
a superbug: Candida auris Tom Chiller, USA16:15 S2.2d Skin and surface disinfection challenges for the emerging
pathogen Candida auris Ryan Kean, United Kingdom
S2.3 Antifungal stewardshipE102 Convener: Martin Hönigl, Austria
15:00 S2.3a Azole prophylaxis: Cost-effective strategies and money wasters Jürgen Prattes, Austria 15:25 S2.3b Echinocandins in patients with hematologic malignancies:
Indications, dosage, costs and outcome Werner Heinz, Germany15:50 S2.3c Emerging diagnostics for invasive mould infections and
diagnostic driven treatment strategies Sophia Koo, USA 16:15 S2.3d Impact of infectious diseases consultation on mortality in patients
with candidemia Andrej Spec, USA
SUN
DAY
14
17:20 S3.3c Immunodeficiencies associated with indoor mold exposures and persistent illness, and available immune therapies
Irene Grant, USA17:45 S3.3d Aspergillus ochraceus: a potential fungal allergen Sara Gago, United Kingdom
S3.4 ISHAM Working Group: Veterinary MycologyE104 Conveners: Amir Seyedmousavi, USA & Jacques Guillot, France
16:30 S3.4a Batrachochytrium salamandrivorans infections in amphibians Ann Martel, Belgium16:55 S3.4b Cryptic species, cats and aspergillosis Vanessa Barrs, Australia17:20 S3.4c Trichophyton benhamiae a zoonotic fungal pathogen Vit Hubka, Czech Republic17:45 S3.4d The serial killer Saprolegnia – biofilm formation and combat
strategies Ida Skaar, Norway
S3.5 PneumocystisE107 Convener: Alexandre Alanio, France
16:30 S3.5a Is Pneumocystis jirovecii a commensal of the respiratory tract of humans? Sergio Vargas, Chile16:55 S3.5b Pneumocystis species in mammals: how different are they? Patrizia Danesi, Italy 17:20 S3.5c Pneumocystis jirovecii detection in asymptomatic patients: what
does its natural history tell us? Alexandre Alanio, France17:45 S3.5d Pneumocystis jirovecii colonization in pregnant women Alejandra Calderón Hernández, Spain
S3.6 Late breakers E108 Chair: Judith Berman, Israel
16:30 S3.6a Human and veterinary blastomycosis caused by Blastomyces helicus and B. percursus identified among global fungal collections Ilan Schwarz, Canada
16:45 S3.6b Identification of a potent HIV latency reversal agent from a screen of secondary fungal metabolites Tokameh Mahmoudi, the Netherlands
16:30 – 18:00 Parallel session III
S3.1 Evolutionary strategies of fungal pathogensE103 Convener: Eveline Snelders, the Netherlands
16:30 S3.1a Genome evolution in Candida albicans Richard Bennet, USA16:55 S3.1b Sexual reproduction and the evolution of eukaryotic microbial
pathogens Joseph Heitman, USA17:20 S3.1c Understanding the role of the natural life history of Aspergillus
fumigatus in azole resistance development Bas Zwaan, the Netherlands17:45 S3.1d Genome sequencing reveals infection mechanisms for two
amphibian infecting chytrid species Rhys Farrer, United Kingdom
S3.2 AIDS-related mycosesForum Conveners: Darius Armstrong James, United Kingdom &
Vishnu Chaturvedi, USA
16:30 S3.2a Host recognition and clearance of Pneumocystis: Investigating immune mediators and mechanisms
Claire Hoving, South Africa16:55 S3.2b AIDS-related histoplasmosis in Latin America Antoine Adenis, French Guyana17:20 S3.2c AIDS-related mycoses in South East Asia Thuy Le, USA17:45 S3.3d Talaromyces spp., new emerging pathogen in Jakarta, Indonesia:
Analyses of clinical and animal isolates Sem Samuel Surja, Indonesia
S3.3 Indoor fungi and sick buildingsE102 Conveners: Jos Houbraken, the Netherlands & Irene Grant, USA
16:30 S3.3a Clinical Findings After Hazardous Indoor Microfungal Trichothecenes Mycotoxin Exposure: Disability outcomes risk analysis, immunosuppression and impaired genetic MTHFR detoxification status
Irene Grant, USA16:55 S3.3b Chronic pain, indoor mold exposure, mycotoxin excretion, and
response to antifungal therapy James Dillard, USA
15
SUN
DAY
Speakers: • Oliver Cornely, Germany - EiC – Mycoses • Christophe Hennequin, France - EiC- J Mycologie Medicale, • Guillermo Quindos, Spain - EiC - Revista Iberoamericana de
Micología • Oliver Kurzai, Germany – EiC - Medical Mycology Case Reports • Vishnu Chaturvedi, USA – EiC - Mycopathologia • Karl V. Clemons, USA – EiC - Medical Mycology
18:00 – 19:00 Poster Pitch session II Ruby Lounge View the full program on page 47
19:00 – 21:00 ISHAM/ECMM/GAFFI Outreach Evening Africa, Japan E106 and China This evening program is only accessible for invited delegates.
17:00 S3.6c Invasive deep dermatophytosis associated with CARD 9 immunodeficiency successfully treated with allogenic stem cell transplant-Report of two cases Flavio Queiroz Telles, Brazil
17:15 S3.6d Influenza-associated aspergillosis: is there a place for antifungal prophylaxis Joost Wauters, Belgium
17:30 S3.6e Emergence of clinical and mycological resistance in T. interdigitale infections in North India Ashutosh Singh, India
17:45 3.6f Managing the introduction of Candida auris into the UK Colin Brown, USA
S3.7 Behind the scene of scientific publishingE105 Moderators: Vishnu Chaturvedi, USA & Karl Clemons, USA This will be an interactive session between the participants who
are all the editor in chief of a journal, which publishes papers on fungi and fungal infections. Participants will give an overview of the workings of their journal for the editorial process and resources available to prospective authors. In addition, the participants will offer their thoughts on the future directions of publication. The audience will be able to ask questions and obtain the opinions of these experts on any of the topics pertaining to publication of scientific studies.
Session highlights: • Introduce the history and current focus of each journal • Value of citation indices and other evaluations of your journal? • Author resources provided by the publisher • How the papers are assessed initially, how editorial and review
decisions are made, and what leads to a rejection? • What to do if a paper is rejected? • Open access, publication charges, plagiarism, and other topics • How young scientists can participate as future reviewers and
editors? • Online only or print or hybrid models, and the future direction of
publishing • Ask an editor?’ (Audience interactions)
1716
Monday 2 July 2018
09:00 – 10:00 PS3 Translational mycology / From laboratory discovery toForum patient care Donald Sheppard, Canada
10:00 – 10:30 Coffee break Forum & Ruby Lounge
10:30 – 12:00 Parallel session IV
S4.1 Molecular and cell biology of fungal pathogensE103 Convener: Neil Gow, United Kingdom
10:30 S4.1a The cell biology of cell walls of fungal pathogens and the interaction with immune cells
Neil Gow, United Kingdom10:55 S4.1b Cell biology and structure of the Candida cell wall Megan Lenardon, Australia11:20 S4.1c Haploid Candida albicans as a powerful tool for new discoveries Yue Wang, Singapore 11:45 S4.1d Dysfunction in complex I of Candida albicans influences the
phagocytosis and killing ability of macrophage and colonization in mice intestine
Xiaodong She, China
S4.2 Cryptococcal meningitis clinical trialsForum Convener: Tihana Bicanic, United Kingdom
10:30 S4.2a ACTA and beyond Thomas Harrison, United Kingdom10:55 S4.2b New and novel agents for prevention of cryptococcal disease David Boulware, USA11:20 S4.2c AmBition-CM: High dose Liposomal Amphotericin for HIV related
cryptococcal meningitis William Hope, United Kingdom 11:45 S4.2d Dynamic ploidy changes drive emergence of fluconazole
resistance in human cryptococcal meningitis Neil Stone, United Kingdom
MONDAY 2 JULY 2018
1918
MO
ND
AY
20
S4.6 MMCR case report session E108 Conveners: Oliver Kurzai, Germany & Katrien Lagrou, Belgium
10:30 S4.6a Case 1 Shivaprakash Rudramurthy, India 10:55 S4.6b Case 2 Jochem Buil, the Netherlands 11:20 S.4.6c Case 3 Rachel Caligiorne, Brazil11:45 Discussion
12:00 – 13:30 Lunch break Forum & Ruby Lounge
12:15 – 13:15 Poster Pitch session IIIRuby Lounge View the full program on page 51
13:30 – 14:30 PS4 Clinically validation and implementation of next generationForum sequencing into a clinical laboratory for patient care testing Chair: Ferry Hagen, the Netherlands Sean Zhang, USA
14:30 – 15:00 Coffee break Forum & Ruby Lounge
15:00 – 16:30 Parallel session V S5.1 Hot topics in Taxonomy - Can we define fungal species borders? E103 Convener: June Kwon-Chung, USA
15:00 S5.1a Viewing species complexes through a phylogenomic lens – the Curious Case of Cryptococcus
David Engelthaler, USA15:25 S5.1b What should be the ideal criteria for species delimitation in
pathogenic fungi? John Taylor, USA15:50 S5.1c Mitochondrial genomes and species boundaries in the genus
Fusarium Balász Brankovics, the Netherlands16:15 S5.1d Evolution of virulence genes and cryptic speciation in the fungal
pathogen Histoplasma Victoria Sepúlveda, USA
21
S4.3 Antifungals Pipeline session E102 Chair: Roger Brüggeman, the Netherlands
10:30 S4.3a CD101 – Cidara Taylor Sandison, USA 10:50 S4.3b F901318 - F2G John Rex, United Kingdom11:10 S4.3c SCY-078 – Scynexis David Angulo, USA 11:30 S4.4d VT-1598 – Viamet Edward Garvey, USA 11:40 Discussion
S4.4 Invasive infections in AsiaE104 Conveners: Arunaloke Chakrabarti, India & Ruo-yu Li, China
10:30 S4.4a The unique features and challenges of yeast infections in Asia: focus on Candida tropicalis
Yee-Chun Chen, Taiwan10:55 S4.4b Black mycelial fungal infection with special reference t Cladophialophora bantiana Asian perspectives Retno Wahyuningsih, Indonesia11:20 S4.4c How to guard the mimic fungal infection in Asia? Ariya Chindamporn, Thailand11:45 S4.4d Fereydounia khargensis, an emerging Ustilaginomycetous
opportunistic yeast, and antifungal resistances Ratna Mohd tap, Malaysia
S4.5 New insights in the management of invasive fungal disease E107 haematology Convener: Peter Donnelly, the Netherlands
10:30 S4.5a Invasive aspergillosis: New risk groups Livio Pagano, Italy10:55 S4.5b New management strategies (EORTC study) Peter Donnelly, the Netherlands11:20 S4.5c New antifungals (isavuconazole, new formulations of
posaconazole, drugs in the pipeline) Johan Maertens, Belgium 11:45 S4.5d New guidelines (ECCMID Aspergillus, IDSA Aspergillus and ECIL2017) Fanny Lanternier, France
22
S5.5 From Basic Science to Patient Care E107 Convener: Dieter Buchheidt (DMykG) & Jacques Meis, the Netherlands
15:00 S5.5a Translating antifungal immunology into patient care Frank van de Veerdonk, the Netherlands15:25 S5.5b Translating mycology into patient care Oliver Kurzai, Germany15:50 S5.5c Clinical challenges in the management of invasive fungal infections Andreas Groll, Germany16:15 S5.6d Candida auris: understanding the mechanisms of host immune
response Mariolina Bruno, the Netherlands
S5.6 ISHAM Working Group: FusariumE108 Conveners: Anne van Diepeningen & Abdullah Al-Hatmi, Oman
15:00 S5.6a The trans-kingdom pathogen Fusarium Anne van Diepeningen, the Netherlands15:25 S5.6b Fusarium keratitis: the species and their occurrence Grit Walther, Germany15:50 S5.6c Intrinsic resistance to antifungals Joseph Meletiadis, Greece16:15 S5.6d Histological characterization and host response during Fusarium
solani infection in an ex-vivo human skin model Dora Corzo-Leon, United Kingdom
16:30 – 18:00 Parallel session VI
S6.1 Functional genomics and systems biologyE103 Convener: Berhard Hube, Germany
S6.1a QPCR detection of Mucorales DNA in bronchoalveolar lavage fluid for pulmonary mucormycosis diagnosis
Laurence Millon, France S6.1b Antifungal tolerance is a subpopulation effect distinct from
resistance and is associated with persistent candidemia Judith Berman, Israel S6.1c Functional genomics of Candida species Geraldine Butler, Ireland S6.1d Comparative genomics for understanding the development of
multidrug resistance in Candida lusitaniae Dominique Sanglard, SwitzerlandM
ON
DAY
S5.2 Superficial dermatophytesForum Conveners: Ryoji Tsuboi, Japan & Ruoyu Li, China
15:00 S5.2a Epidemiology and clinical implication of dermatophytes and nondermatophytes in South East Asia Sumanas Bunyaratavej & Charussri Leeyaphan, Thailand15:25 S5.2b Cutaneous infection by zoonotic dermatophytes: an update Pei-lun Sun, Taiwan15:50 S5.2c Molecular epidemiology of dermatophytoses Mochizuki Takashi, Japan16:15 S5.2d New oral and topical treatments for onychomycosis Ryoji Tsuboi, Japan
S5.3 Beyond antifungal / host directed therapyE102 Convener: Mihai Netea, the Netherlands
15:00 S5.3a Host-directed therapy in candidemia Mihai Netea, the Netherlands15:25 S5.3b New insights in diagnosis and immunopathology of aspergillosis Agostinho Carvalho, Portugal 15:50 S5.3c New insights in Cryptococcus infections Robin May, United Kingdom16:15 S5.3d Quantifying host-pathogen interaction in blood from patients
with selected immunodeficiencies Kerstin Hünniger, Germany
S5.4 Mucoralean infectionsE104 Convener: Anna Skiada, Greece
15:00 S5.4a Managing mucormycosis: why is it so difficult? Ashraf Ibrahim, USA15:25 S5.4b Diagnostics: From histopathology and cultures to qPCR and Birgit Willinger, Austria15:50 S5.4c Challenging Cases of Mucormycosis Rajeev Soman, India16:15 S5.4d Mucormycosis in patients with hematological diseases after
hematopoietic stem cell transplantation and chemotherapy Yuliya Rogacheva, Russia
23
MO
ND
AY
24
S6.5 Malassezia in humans and animalsE107 Conveners: Jacques Guillot, France & Teun Boekhout,
the Netherlands
16:30 S6.5a Analysis of Malassezia microbiota in humans and animals: does it really help us to better understand and control Malassezia-related diseases?
Jacques Guillot, France16:55 S6.5b The human skin microbiome: cause or effect? The role of
Malassezia in human skin health and disease Thomas Dawson, Singapore17:20 S6.5c The overgrowth of Malassezia spp. in canine atopic dermatitis
– the reason or the result of disease? Bozena Dworecka-Kaszak, Poland17:45 S6.5d Characterization of growth of lipid-dependent Malassezia yeast
species, members of the skin mycobiome Hans de Cock, the Netherlands
S6.6 Surveillance azole resistanceE108 Convener: Jacques Meis, the Netherlands
16:30 S6.6a Surveillance of azole resistance in Colombia Patrice le Pape, France16:55 S6.6b Surveillance and status quo of azole resistant Aspergillus in
East Asia Chi-Jung Wu, Taiwan 17:20 S6.6c First report of azole-resistant Aspergillus fumigatus harbouring TR34/L98H and M220R in Brazil Laura Bedin Denardi, Brazil17:45 S6.6d Status and Surveillance of Azole Resistance in North America Elizabeth Berkow, USA
18:00 – 19:00 Poster Pitch session IVRuby Lounge View the full program on page 55
19:00 – 00:30 Young ISHAM Beach Party More information is available on page 64
19:00 – 21:00 ISHAM/ECMM/GAFFI Outreach Evening Eastern Europe E106 This evening program is only accessible for invited delegates
S6.2 ABPAForum Convener: Ritesh Agarwal, India
16:30 S6.2a Recent advances in allergic bronchopulmonary aspergillosis complicating asthma Arunaloke Chakrabarti, India16:55 S6.2b Severe asthma with fungal sensitization David Denning, United Kingdom17:20 S6.2c Recent advances in allergic bronchopulmonary aspergillosis
cystic fibrosis Richard Moss, USA17:45 S6.2d A new Aspergillus fumigatus Western Blot assay for IgE
sensitization and Allergic Broncho Pulmonary Aspergillosis diagnosis
Raphael Piarroux, France
S6.3 Tropical implantation diseasesE102 Convener: Flavio Queiroz-Telles, Brazil
16:30 S6.3a Management of chromoblastomycosis: difficulties, challenges and perspectives in developing countries
Lala Soavina Ramarozatovo, Madagascar16:55 S6.3b The expanding cat-transmitted sporotrichosis in Brazil Anderson Rodrigues, Brazil 17:20 S6.3c Diversity among coelomycetous isolates from cutaneous and
subcutaneous infections Dea Garcia-Hermoso, France17:45 S6.3d Conidiobolomycosis: presentation of two cases in adult and
infant Alexandro Bonifaz, Mexico
S6.4 Aspergillus terreus frontlineE104 Convener: Cornelia Lass-Flörl, Austria
16:30 S6.4a The Aspergillus terreus species complex: What is new Jesus Guinea, Spain 16:55 S6.4b Outcome and treatment of Aspergillus terreus infections Oliver Cornely, Germany17:20 S6.4c Amphotericin B resistance: New insights Cornelia Lass-Flörl, Austria17:45 S6.4d Molecular epidemiology and antifungal susceptibility profiles of Aspergillus terreus in Iran Afsane Vaezi, Iran
25
TUESDAY 3 JULY 2018
26 27
Tuesday 3 july 2018
09:00 – 10:00 PS5 The evolving role of infection control in mycology Forum Chair: Paul Verweij, the Netherlands Andreas Voss, the Netherlands
10:00 – 10:30 Coffee break Forum & Ruby Lounge
10:30 – 12:00 Parallel session VII
S7.1 Fungal biofilmsE103 Convener: Gordon Ramage, United Kingdom
10:30 S7.1a Candida auris and non-albicans biofilms Gordon Ramage, United Kingdom10:55 S7.1b insights into new antibiofilm molecules Jose Lopez-Ribot, USA11:20 S7.1c Fungal-bacterial biofilms: consequences in an intra-abdominal
infection model Mairi Noverr, USA11:45 S7.1d Deciphering the global transcriptomic profile of Candida glabrata
during biofilm and planktonic growth phase Khem Raj, India
S7.2 Fungal Interactions with Epithelium Trigger Innate Immune Activation
E106 Convener: Andrew Limper, USA
10:30 S7.2a Epithelial Activation by Candida species Julian Naglik, United Kingdom 10:55 S7.2b The Immunopathogenesis of Candida vaginitis Paul Fidel, USA11:20 S7.2c Pneumocystis Activation of Innate Immune Responses by Lung
Epithelial Cells Andrew Limper, USA11:45 S7.2d Differential gene expression of Aspergillus fumigatus and
Aspergillus niger interacting with epithelial lung cells Esther Keizer, the Netherlands
TUES
DAY
28
S7.6 ISHAM Working Group: SporothrixE107 Convener: Leila Lopes-Bezerra, Brazil
10:30 S7.6a RNA-seq and transcriptome-wide analysis of Sporothrix schenckii yeast and mycelial forms
Orazio Romeo, Italy10:55 S7.6b Sporothrix globosa causing sporotrichosis in Jilin Province
(Northeast of China): Prevalence, molecular characterization, and antifungal susceptibility
Shanshan Li, China11:20 S7.6c Human serum factors impact the interaction of Sporothrix spp.
With human macrophages Leila Lopes-Bezerra, Brazil11:45 S7.6d Cutaneous disseminated sporotrichosis: Clinical experience of 24
cases Alexandro Bonifaz, Mexico
S7.7 PediatricsE108 Convener: Andreas Groll, Germany
10:30 S7.7a Antifungal prophylaxis and treatment – current choices and strategies in children
Andreas Groll, Germany 10:55 S7.7b Diagnostic biomarkers and imaging – what is different in pediatrics Thomas Lehrnbecher, Germany11:20 S7.7c Epidemiology and outcome of IFD in pediatrics patients:
The Southern hemisphere Fabianne Carlesse, Brazil 11:45 S7.7d Epidemiology and outcome of IFDs in pediatrics patients:
The Northern Hemisphere Emmanuel Roilidis, Greece
12:00 – 13:30 Lunch break Forum & Ruby Lounge
12:15 – 13:15 Poster Pitch session VRuby Lounge View the full program on page 59
13:30 – 14:30 PS6 Antifungal drug discovery comes of ageForum Chair: Martin Hönigl, Austria John Rex, United Kingdom
14:30 – 15:00 Coffee break Forum & Ruby Lounge
S7.3 The Real Pathogens: AjellomycetaceaeForum Conveners: Anastasia Litvintseva, USA & Vishnu Chaturvedi, USA
10:30 S7.3a Emerging Emergomyces africanus in Africa Nelesh Govender, South Africa10:55 S7.3b Migration of Coccidioides posadasii into South America Bridget Barker, USA11:20 S7.3c Ecology and geographic distribution of Coccidioides Anastasia Litvintseva, USA11:45 S7.3d Molecular epidemiology of Colombian Histoplasma capsulatum
(Hc) isolates showed their polyphyletic behavior and indicated chicken manure as one infection source
Luisa Fernanda Gómez Londoño, Colombia
S7.4 Why do patients get aspergillosis? E102 Convener: Adilia Warris, United Kingdom
10:30 S7.4a Influenza-associated aspergillosis Frank van de Veerdonk, the Netherlands10:55 S7.4b Aspergillus-derived secreted products driving invasion of
pulmonary epithelia Elaine Bignell, United Kingdom 11:20 S7.4c Defective antifungal immunity in cystic fibrosis Adilia Warris, United Kingdom11:45 S7.4d Increased incidence of invasive aspergillosis in patients receiving
empiric carbapenem in febrile neutropenia Chai Louis, Singapore
S7.5 ScedosporiumE104 Conveners: Sharon Chen, Australia & Michaela Lackner, Austria
10:30 S7.5a Enzymatic antioxidant defense systems in Scedosporium species Jean-Philippe Bouchara, France10:55 S7.5b N-chlorotaurine, a potential agent for the topical treatment of
scedosporiosis and lomentosporiosis Michaela Lackner, Austria11:20 S7.5c Diversity within the genera Lomentospora and Scedosporium José Cano-Lira, Spain11:45 S7.5d “S.O.S.”: The Nationwide French Scedosporiosis Observational
Study (2005 2017) Franny Lanternier, France
29
TUES
DAY
30
S8.4 DNA BarcodingE102 Convener: Wieland Meyer, Australia
15:00 S8.4a Advances is DNA barcoding of pathogenic fungi Wieland Meyer, Australia15:25 S8.4b From DNA barcoding databases to complex systems Vincent Robert, the Netherlands15:50 S8.4c Applying DNA barcoding for clinical diagnosis Gianluigi Cardinali, Italy16:15 S8.4d Improving fungal diagnosis via dual fungal DNA barcoding Minh Thuy Vi Hoang, Australia
S8.5 Challenges in mucosal and invasive candidiasisE104 Conveners: Stavroula Antonopoulou, Greece & Jesus Guinea, Spain
15:00 S8.5a Immunity to Candida vaginitis Flavia De Bernardis, Italy15:25 S8.5b Management of complicated and recurrent vulvovaginal
candidiasis Drosos Karageorgopoulos, Greece15:50 S8.5c Hidden echinicandin resistance induction due to abdominal
candida infection Cornelius Clancy, USA16:15 S8.5d Identification of Candida albicans protein kinases, involved in environmental pH modulation and biofilm formation Philipp Brandt, Germany
S8.6 ECMM Educational SymposiumE107 Conveners: Oliver Cornely, Germany & Jean-Pierre Gangneux, France * this symposium continues during parallel session IX and lasts 180 minutes.
15:00 S8.6a Challenges in the treatment of IFD in children Thomas Lernbecher, Germany15:25 S8.6b Genetic predictors of response to antifungals in IFD Michaela Lackner, Austria 15:50 S8.6c Rare fungal infections – Experience of the German National Reference Center NRZMyk Oliver Kurzai, Germany16:15 S8.6d Going steady: FungiScope, a worldwide effort in researching rare
fungal diseases Danilia Seidel, Germany
15:00 – 16:30 Parallel session VIII
S8.1 Host-pathogen interactions - the pathogen perspectiveE103 Convener: Bernhard Hube, Germany
15:00 S8.1a Interactions of Candida albicans with the host Bernhard Hube, Germany15:25 S8.1b The immunoglycobiology of fungal pathogens Héctor Mora-Montes, Mexico15:50 S8.1c The cell wall of A.fumigatus and its impact on fungal virulence Jean-Paul Latge, France16:15 S8.1d Discussion
S8.2 Milestones in medical mycology: history in modern lightE106 Convener: Luciano Polonelli, Italy
15:00 S8.2a Taxonomic benchmarks in mycotoxinogenic fungi Robert Samson, the Netherlands15:25 S8.2b Nystatin and the women who founded the antifungal era Chet Cooper, USA 15:50 S8.2c History of Cryptococcus and cryptococcosis Wanqing Liao, China 16:15 S8.2d The history of medical mycology within the ISHAM Luciano Polonelli, Italy
S8.3 Management of fungal resistanceForum Convener: Oliver Lortholary, France
15:00 S8.3a Does antifungal résistance influence the therapeutic decision during invasive candidiasis
Oliver Lortholary, France15:25 S8.3b Antifungal therapy for C parapsilosis candidemia: who are the
heroes and villains Arnaldo Colombo, Brazil15:50 S8.3c Infections with Scedosporium/Lomentospora from an Australian perspective are we at the end of the road Sharon Chen, Australia 16:15 S8.3d Voriconazole resistance and mortality in 196 Aspergillus
fumigatus culture positive patients with invasive aspergillosis Pieter Lestrade, the Netherlands
31
TUES
DAY
32
16:55 S9.1b NGS in the era of drug resistant Aspergillus fumigatus Johanna Rhodos, United Kingdom 17:20 S9.1c NGS and typing of Candida albicans: just an improvement of
other typing methods? Christophe d’Enfert, France17:45 S9.1d Whole genome sequencing of P. brasiliensis isolates of endemic
areas in Argentina and Paraguay Maria Cattana, Argentina
S9.2 Developments in Chinese medical mycology E106 Convener: Ruoyu Li, China
16:30 S9.2a Anti–Interferon-? autoantibodies are underlie the disseminated Talaromyces marneffei infection
Cunwei Cao, China16:55 S9.2b CARD9 deficiency and dematiaceous fungal infections Xiaowen Wang, China17:20 S9.2c Exploring the pathogenic roles of Fonsecaea cell wall melanin
through case to bench study Jiufeng Sun, China17:45 S9.2d Coccidioidomycosis: Imported and possible domestic cases in
China, a review from 1958 to 2017 Guanzhao Liang, China
S9.3 Dosing antifungal from the XXS to XXXL Forum Convener: Roger Brüggeman, the Netherlands
16:30 S9.3a Impact of critical illness on antifungal drug pharmacokinetics - need for individualisation of therapy?
Roger Brüggeman, the Netherlands 16:55 S9.3b From mother to child and their ontogeny with a focus on
antifungal drugs Catherine Sherwin, USA17:20 S9.3c The heavy weight championship – impact of obesity on
pharmacokinetics and dynamics Catherijne Knibbe, the Netherlands17:45 S9.3d Serum isavucoanzole (ISA) troughs in adult solid organ transplant
patients (SOT pts) receiving prophylaxis Hong Nguyen, USA
16:40 S8.6e Taxonomy of Mucor Lysett Wagner, Germany 17:05 S8.6f Challenges in clinical management of mucormycosis in children Zoi Pana, Greece17:30 S8.6g Rare invasive yeast infections Luisa Durán Graeff, Chile17:55 Discussion
S8.7 New developments in dermatomycosisE108 Convener: Pietro Nenoff, Germany
15:00 S8.7a Inflammation of the gut alters the microbial balance and leads to Candida glabrata cell wall remodeling
Samir Jawhara, France15:10 S8.7b Antifungal drug resistance of Trichophyton clinical isolates Michel Monod, Austria15:20 S8.7c Trichophyton mentagrophytes genotype Thailand Type 1 as
causative pathogen of abscessing dermatophytoses - tinea genitalis and barbae - in Germany(2012–2017) in Greece
Pietro Nenoff, Germany15:30 S8.7d Survey on dermatophyte infections over the past 6 years
(2012–2017) in Greece Michael Arabatzis, Greece15:40 S8.7e Validation of the DermaGenius® 2.0; a multiplex real-time PCR for
the identification of dermatophytes species in nail, hair and skin Giel Gaajetaan, the Netherlands15:50 S8.7f An alarming epidemic of clinically striking and frequently
relapsing steroid-modified dermatophytoses in India – a public health concern
Pietro Nenoff, Germany16:00 S8.7g Hair fungal Infection - precise diagnosis and therapeutic effect
evaluation by dermoscopy and fluorescent staining Yuping Ran, China16:10 S8.7h Discussion
16:30 – 18:00 Parallel session IX
S9.1 Genotyping in the NGS eraE103 Convener: Stephane Bretagne, France & Colin Brown, USA
16:30 S9.1a Tracing the evolution of virulence in Cryptococcus neoformans using population sequencing
Christina Cuomo, USA
33
TUES
DAY
34
16:50 S9.7c Titan cell production reshapes Cryptococcus neoformans cell surface composition in order to modulate and/or evade the host immune system
Liliane Mukaremera, USA17:00 S9.7d Macrophage immune modulation by Secreted Molecules from Cryptococcus neoformans during infection Pedro Henrique Bürgel, United Kingdom 17:10 S9.7e The impact of extracellular vesicles on Cryptococcus neoformans
transmigration across brain endothelial cells Vanessa Silva, United Kingdom17:20 S9.7f Pathogenesis of clinical and environmental isolates of
Cryptococcus neoformans and Cryptococcus gattii in human brain microvascular endothelial cells: A comparative
Shayanki Lahiri Mukhopadhyay, India17:30 S9.7g Mismatch repair of DNA replication errors contributes to
microevolution and the emergence of resistance to antifungal drugs in Cryptococcus neoformans
Kylie Boyce, Australia 17:40 S9.7h Non-lytic exocytosis of Brazilian Cryptococcus neoformans clinical
isolates from macrophages André Nicola, Brazil17:50 Discussion
18:15 Departure canal cruises to congress dinnerStrandZuid Please see page 64 for more information
19:30 Congress dinner KIT Royal Please see page 64 for more information Tropical Institute
S9.4 MALDI-TOF in filamentous fungiE102 Convener: Maurizio Sanguinetti, Italy
16:30 S9.4a MALDI-TOF for molds, identification and beyond Maurizio Sanguinetti, Italy16:55 S9.4b Filamentous fungi MALDI-TOF identification in the clinical
laboratory Stephane Ranque, France17:20 S9.4c Maldi-Tof MS for the identification of filamentous fungi; a success
story outside the boundaries of the clinical lab? Marijke Hendrickx, Belgium17:45 S9.4d MALDI -TOF MS based identification of clinically important moulds
is faster and reliable- an experience from India Anup Ghosh, India
S9.5 Recent advances in diagnosing aspergillosisE104 Convener: Koichi Izumikawa, Japan
16:30 S9.5a How to standardize Aspergillus PCR protocols for testing various specimens
Lewis White, United Kingdom16:55 S9.5b Aspergillus identification by volatile organic compounds release Simona Cristescu, the Netherlands17:20 S9.5c Detection of invasive pulmonary aspergillosis in mice using lung
perfusion single photon emission computed tomography with 99mTc-MAA
Masato Tashiro, Japan 17:45 S9.5d AsperGenius versus MycoGENIE: Comparison of two commercial
Realtime PCR assays for detecting Aspergillus fumigatus in respiratory specimens
Dirk Schmidt, Germany
S9.7 Cryptococcus-host interactionsE108 Chair: Robin May, United Kingdom
16:30 S9.7a The Hormonal Milieu and its Effects on Virulence of Cryptococcus neoformans Tiffany Guess, USA16:40 S9.7b The effect of nutrient and temperature stress on the urease of the
opportunistic pathogen Cryptococcus neoformans Barbra Lerm, South Africa
35
Wednesday 4 july, 2018
09:00 – 10:00 PS6 Translational mycology / From laboratory discovery to Forum patient care Chair: Sybren de Hoog, the Netherlands Axel Brakhage, Germany
10:00 – 10:30 Coffee break Forum & Ruby Lounge
10:30 – 12:00 Parallel session X
S10.1 The technical revolutions ahead of us NGS, proteomics,E103 Crispr-cas Convener: Sean Zhang, USA
10:30 S10.1a Genomic epidemiology of Candida auris within the United Kingdom, and the future of whole genome sequencing typing
Johanna Rhodes, United Kingdom10:55 S10.1b Applications of mass spectrometry for rapid and accurate
identification of molds and yeasts Joanna Freeke, Finland11:20 S10.1c Disruption of cotH genes of Mucor circinelloides via a plasmid-
free CRISPR/Cas9 system Csilla Szebenyi, Hungry 11:45 S10d Using CRISPR/Cas9 to unravel the complex role of single
nucleotide substitutions in Aspergillus fumigatus in-host adaptation
Eloise Ballard, United Kingdom
S10.2 ISHAM Working Group: Fungal PCR InitiativeE106 Convener: Peter Donnelly, the Netherlands
10:30 S10.2a The FPCRI past, present and future Rosemary Barnes, United Kingdom10:55 S10.2b Laboratory aspects Lewis White, United Kingdom11:20 S10.2c Clinical and translational aspects Mario Cruciani, Italy11:45 Discussion
WEDNESDAY 4 JULY, 2018
36 37
WED
NES
DAY
38
11:10 S10.5c Isothermal amplification techniques, a tool for molecular diagnosis of eumycetoma
Sara Ahmed, Sudan11:25 S10.5d Development of Madurella mycetomatis Short Tandem Repeat
(MmySTR) assay for studying the genetic variance between different isolates
Bertrand Nyuykonge, the Netherlands11:40 Panel discussion – Closing the gap Discussion leader: Ahmed Hassan Fahal
S10.6 Fungal respiratory infections in Cystic FibrosisE107 Convener: Jean-Philippe Bouchara, France
10:30 S10.6a Treatment of airway colonization/respiratory infections with fungal pathogens
Carsten Schwarz, Germany10:55 S10.6b Developing omics approaches to elucidate pathogenic
mechanisms in Scedosporium species Nicolas Papon, France11:20 S10.6c Adaptation strategies of Aspergillus fumigatus in cystic fibrosis
patients Tobias Engel, the Netherlands11:45 S10.6d Serum (1?3)-ß-D-glucan and galactomannan levels in patients
with Cystic Fibrosis: a retrospective cohort study Jürgen Held, Germany
S10.7 Candida aurisE108
10:30 S10.7a Candida auris: report of the first case of infection from Australia Christopher Heath, Australia 10:40 S10.7b Internal validation of GPS™ CanAur dtec-qPCR Test following the
UNE/EN ISO/IEC 17025:2005 for detection of emergent nosocomial Candida auris
Antonio Martínez-Murcia, Spain10:50 S10.7c Genetic diversity, phenotypic variability and drug resistance in the
emerging fungal pathogen Candida auris Alexandre Lorenz, United Kingdom11:00 S10.7d Applicability of MALDI-TOF MS for rapid detection of resistant C.
auris strains to caspofungin Mansour Vatanshenassan, Germany
39
S10.3 ISHAM-EFISG symposium: From non-responder to fungalForum breakthrough infections by opportunistic yeasts and molds Conveners: Sevtap Arikan-Akdagli, Turkey & Cornelia Lass-Flörl,
Austria
10:30 S10.3a How to define “non responder” and “fungal breakthrough” in yeasts and molds
Andreas Groll, Germany 10:55 S10.3b Current epidemiological trends: from prevalence to risk factors Ana Alastruey-Izquierdo, Spain11:20 S10.3c How to manage treatment failures Olivier Lortholary, France11:45 S10.3d Breakthrough fungal infections in solid organ transplant (SOT)
recipients receiving prophylaxis with isavuconazole and other antifungal agents
Cornelius Clancy, USA
S10.4 Ecology and outbreaksE102 Convener: Shawn Lockhart, USA
10:30 S10.4a Exploring the origin of outbreaks of mucormycosis Karlyn Beer, USA10:55 S10.4b Phylogenetic genome-level trees, population genetics and
species delineation in dimorphic fungi: Does it help us understand infection?
Marcus Teixeira, Brazil11:30 S10.4c Candidiasis: What are we missing by only looking in the blood? Hong Nguyen, USA11:45 S10.4d Epidemiological investigation for grouped cases of Trichosporon|
asahii using whole genome sequencing Marie Desnos-Ollivier, France
S10.5 Closing the mycetoma knowledge gapE104 Conveners: Wendy van de Sande, the Netherlands &
Ahmed Hassan Fahal, Sudan
10:30 Introduction Ahmed Hassan Fahal, Sudan10:40 S10.5a A holistic approach to the mycetoma management Sahar Bakhiet, Sudan10:55 S10.5b The treatment landscape of Mycetoma Ed Zijlstra, Switzerland
WED
NES
DAY
40
11:10 S10.7e Azole and echinocandin antifungal drug resistance determinants of Candida auris
Milena Kordalewska, USA11:20 S10.7f Comparison of Candida auris candidemia with non-C. auris
candidemia: risk factors and outcome experience from Pakistan Syed Faisal Mahmood, Pakistan11:30 S10.7g Case-case comparison of Candida auris vs. other Candida
species bloodstream infections in Colombia Diego Cáceres, USA11:40 S10.7h Candida auris in Germany – report of the first clinical cases of an
emerging nosocomial pathogen Axel Hamprecht, Germany11:50 S10.7i Discussion
12:00 – 12:30 Closing Ceremony
41
E-POSTER & POSTER PITCH PRESENTATIONS
PP1.007 Identification and characterization of novel Aspergillus fumigatus mycoviruses
Jan Zoll, the Netherlands PP1.008 Molecular epidemiology and antifungal susceptibility of Aspergillus
species isolated from asthma patients Mohammad Hedayati, Iran
Poster Terminal 2 Chair: Bart-Jan Kullberg, the Netherlands
PP1.041 Allergic bronchopulmonary aspergillosis presenting with lung mass-Report of six cases
Muhammad Irfan, Pakistan PP1.042 Galactomannan antigen as a diagnostic and prognostic marker in ICU
subpopulation suspected of Invasive Aspergillosis Yubhisha Dabas, India PP1.043 Invasive Aspergillosis: Performance of New and Established Diagnostic
Approaches with Same-Day Blood and Bronchoalveolar Lavage -- a Prospective Cohort Study
Sven Heldt, Austria PP1.044 Clinical features and outcome of Chronic Pulmonary Aspergillosis:
experience from a high tuberculosis burden country Nousheen Iqbal, Pakistan PP1.045 In vivo analysis of A. fumigatus sulphur-related transcriptome during
infection using a NanoString nCounter Plattform Monica Sueiro-Olivares, United Kingdom PP1.047 Pleurotus sajor-caju can be used to synthesize silver nanoparticles with
anti-fungal activity against Candida albicans Doblin Sandai, MalaysiaPP1.048 The presence of Candida albicans promotes Proteus mirabilis damage to
enterocytes Ilse Jacobsen, Germany
Poster Terminal 4Chair: Donna MacCallum, United Kingdom
PP1.081 Therapeutic effects of an antibody-derived peptide and its alanine scanning derivatives in a Galleria mellonella model of systemic candidiasis
Elisa Borghi, Italy PP1.082 Understanding the role of biofilms in recurrent vulvovaginal candidiasis
(RVVC) and their impact on therapy Ryan Kean, United Kingdom
E-Posters & Poster Pitch SessionsPosters are submitted electronically and can be retrieved as electronic posters (e-posters) on poster terminals that will be available during the entire congress.
The Poster Pitch Sessions will be held at the poster terminals in the Ruby Lounge.Selected posters will be discussed during the Poster Pitch Sessions. These sessions will have a specific common thematic focus and therefore will give you the opportunity to meet colleagues from other countries working in the same field of interest. The sessions will be guided by experts in the field. After the session there will be opportunity for further discussion.
Sunday 1 July: 12:15 - 13:15 hrs.Sunday 1 July: 18:00 - 19:00 hrs.Monday 2 July: 12:15 - 13:15 hrs.Monday 2 July: 18:00 - 19:00 hrs.Tuesday 3 July: 12:15 - 13:15 hrs.
You can find the E-poster Helpdesk in the Ruby Lounge
SUNDAY 1 JULY 2018Poster Pitch session I 12:15 – 13:15 hrs.Ruby Lounge
Poster Terminal 1Chair: TBA
PP1.001 Azole-resistance in Aspergillus terreus and closely related species, an overseen problem?
Michaela Lackner, Austria PP1.002 Predominance of non-fumigatus Aspergillus species among patients
suspected to pulmonary aspergillosis in a tropical and subtropical region Hossein Zarrinfar, Iran PP1.003 Aspergillosis of the paranasal sinuses Report of 7 cases treated by
Endoscopic Sinus Surgery (ESS) Batool Sadeghi-Nejad, IranPP1.004 Preliminary evaluation of a new immunochromatographic test for anti
Aspergillus antibodies detection Raphael Piarroux, FrancePP1.006 Molecular epidemiology and antifungal susceptibility profiles of
Aspergillus terreus complex Afsane Vaezi, Iran
42 43
44 45
Poster Terminal 6Chair: Marcus Teixeira, USA
PP1.161 A singular case of eumycetoma of right leg due to exophiala jeanselmi Henry Harak, Italy PP1.162 Paracoccidioides antiadhesive peptide shows potential as a broad-
spectrum agent against different fungi Haroldo Cesar De Oliveira, Brazil PP1.163 Phenotyfipication and genotypification of Colombian clinical isolates of
Sporothrix spp from the medical mycology laboratory Universidad de Antiquia, Medellin, Colombia
Laura Carolina Alvarez Acevedo, Colombia PP1.164 Comparative study of lipid composition of the mycelial cell wall from
environmental and clinical isolates of Histoplasma capsulatum Araque Pedronel, Colombia PP1.165 Outbreak of zoonotic sporotrichosis in Southern Brazil Vanice Poester, Brazil PP1.166 Macrophage activation by IFN-? triggers restriction of phagosomal copper
from intracellular pathogens Qian Shen, USA PP1.167 Imaging mass spectrometry and microbial metabolomics on track of
infectious diseases Anton Skriba, Czech RepublicPP1.168 Unravelling the mechanistic basis of methionine synthase essentiality Jorge Amich, United Kingdom
Poster Terminal 8Chair: Cornelia Lass-Flörl, Austria
PP1.201 Prevalence of endobacterial symbiosis in Rhizopus microsporus (Tempe fungus)
Mohammad Javad Najafzadeh, Iran PP1.202 Development of the first commercial real-time PCR assay for the detection
of Mucorales species Giel Gaajetaan, the Netherlands PP1.203 The role of surface proteins in the virulence of Lichthemia corymbifera
with alveolar macrophages Mohamed Ismail Abdelwahab Hassan, Germany PP1.204 Mucormycete virulence and efficiency of posaconazole prophylaxis
depends on the underlying disease Günter Rambach, Austria
PP1.083 Major transcriptional modulations in S. aureus induced by the C. albicans secreted quorum sensing molecule farnesol
Vila Taissa, USA PP1.084 Distribution, Characterization and Antifungal susceptibility pattern of
Candida Species in various Clinical samples at a Multispecialty Hospital – Indian scenario
Swati Salila, India PP1.085 Protein kinase A governs growth and virulence in Candida tropicalis Chi-Jan Lin, Taiwan PP1.087 Comparative genomics of Aspergillus fumigatus and the role of
agricultural azoles on the emergence of resistance Amelia Barber, Germany PP1.088 In vitro antifungal susceptibility testing of Candida isolates from women
with recurrent vulvovaginal candidiasis Drosos Karageorgopoulos, Greece
Poster Terminal 5Chair: Pieter-Jan Haas, the Netherlands
PP1.121 Validation of diagnostic criteria for chronic pulmonary aspergillosis (CPA) Iain Page, United Kingdom PP1.122 Cutaneotrichosporon (Cryptococcus) cyanovorans, a basidiomycetous
yeast, described for the first time from the airways of cystic fibrosis patients Tjomme Van der Bruggen, the Netherlands PP1.123 Prevalence, identification and antifungal susceptibility pattern of Candida
species isolated from Iranian HIV patients with oropharyngeal candidiasis Maryam Roudbary, Iran PP1.124 The prevalence and diversity of fungi in respiratory samples of cystic
fibrosis patients – a Dutch, nationwide, prospective, multicentre study Tobias Engel, the Netherlands PP1.125 Identification of encapsulated viable Cryptococcus neoformans in
bronchoalveolar lavage of the patient with active pulmonary Tuberculosis and relapsing pneumonia
S. Amani Ghayoum, IranPP1.126 Meta-analysis of published molecular epidemiology data of the
Cryptococcus neoformans and C. gattii species complexes using the ISHAM MLST consensus
L. Trilles, Brazil PP1.127 Antifungal susceptibility of Cryptococcus neoformans/gattii spp complex;
Comparison between clinical and environmental isolates Nagarathna Siddaiah, India PP1.128 Interaction of Brazilian Clinical strains of Cryptococcus spp with macrophages Patricia Albuquerque, Brazil
46
SUNDAY 1 JULY 2018Poster Pitch session II 18:00 - 18:15 hrs.Ruby Lounge
Poster Terminal 1 Chair: Bart-Jan Kullberg, the Netherlands
PP2.009 Study the effect of honey ingestion on recognition of Aspergillus fumigatus conidia by peritoneal macrophages
Donya Nikaein, Iran PP2.010 Occurrence of pathogenic Aspergillus species in drinking water from
restaurants in Kathmandu, Nepal Ushana Shrestha Khwakhali, Nepal PP2.011 Transcriptomic analysis of non –invasive infections by Aspergillus
fumigatus: the case of sino-nasal aspergillosis (SNA) in dogs Ivan Valdes, the NetherlandsPP2.012 In vitro combination of voriconazole with micafungin against azole-
resistant clinica isolates of Aspergillus fumigatus from different geographical regions
Hamed Fakhim, Iran PP2.013 Synergistic combinations of glabridin and voriconazole to battle against
Aspergillus fumigatus Mojtaba Nabili, Iran PP2.014 Molecular characterizations and in vitro susceptibility patterns of
Aspergillus fumigatus in a tertiary care hospital, 1999–2016 Weida Liu, China PP2.016 Volatile sulphur compounds produced by Pseudomonas aeruginosa
synergize with Aspergillus fumigatus in vivo enhancing the pathobiology of co-infection
Jorge Amich, United Kingdom
Poster Terminal 2 Chair: TBA
PP2.049 Involvement of iron metabolism in fluconazole susceptibility in Saccharomyces cerevisiae and Candida species
Liesbeth Demuyser, Belgium PP2.050 Cellular apoptosis: an alternative mechanism of action of caspofungin in
Candida glabrata Maryam Moazeni, Iran
PP1.205 Lichtheimia corymbifera: elucidating the mechanisms for iron acquisition and transport during infection
Felicia Adelina Stanford, Germany PP1.206 Multi-center study of Mucorales and other mould contamination of
freshly-laundered linens arriving at U.S. healthcare facilities Hong Nguyen, USA PP1.207 Heterogeneity and within-host adaption observed in clinical isolates of
Aspergillus fumigatus Ivan Valdes, the Netherlands PP1.208 Simple, low-cost micro-culture method for rapid diagnosis of
mucormycosis in murine model Hamid Badali, Iran
47
48
PP2.096 Essential requirements for Candida albicans mediated damage of epithelial cells
Selene Mogavero, Germany
Poster Terminal 5Chair: Ferry Hagen, the Netherlands
PP2.129 Natural habitats of Cryptococcus neoformans and C gattii in the Caribbean Harish Gugnani, India PP2.130 Clinico-microbiological profile of Cryptococcal infections in non-HIV
infected patients Rungmei Marak, India PP2.131 The Effect of Novel Heterocyclic Compounds on Cryptococcal Biofilm Maya Korem, Israel PP2.132 Inflammasome modulation by Cryptococcus neoformans extracelular
vesicles produced in different conditions Clara Luna Freitas Marina, Brazil PP2.133 Antifungal activity of scorpions’ venom-derived antimicrobial peptides
against clinical isolates of Cryptococcus neoformans Fernanda Guilhelmelli Costa, Brazil PP2.134 Immunomodulatory effects of a scorpion-venom derived antimicrobial
peptide during the interaction of Cryptococcus neoformans with murine macrophages and dendritic cells
Calliandra De-Souza-Silva, Brazil PP2.135 Inducing pathogenicity of naive environmental C. neoformans var. grubii
isolates Hai Trieu Phan, Vietnam PP2.136 Phylogenetic analyses and B-cell epitope mapping of virulence factors of
C. neoformans and C. gattii: An in-silico insight Karuna Singh, India
Poster Terminal 6Chair: TBA
PP2.169 Cell wall robustness maintained under antibiotic stress by balanced synthesis of glucan and chitin
Jehan Abdel-moneim Abdelaziz, United Kingdom PP2.170 Fruits are Vehicles of Drug Resistant Pathogenic Yeasts Hsiu-Jung Lo, Taiwan PP2.171 Diagnosis of invasive fungal infections through detection of a circulating
pan fungal disaccharide by mass spectrometry. A european multicenter study Daniel Poulain, France
PP2.051 The Newly Characterization of a Candida albicans Isolate from a recurrent Cervica Lymphadenitis Patient and its Clinic Indication
Changzhen Zang, China PP2.052 Epitope unmasking in vulvovaginal candidiasis is associated with hyphal
growth and neutrophilic infiltration Eva Pericolini, Italy PP2.053 Candida glabrata epithelial cell damage Marina Pekmezovic, Germany PP2.054 Novel formulated nanocomposite containing Indolicidin and Graphene
Oxide against Candida albicans: in vitro and in vivo study Maryam Roudbary, Iran PP2.055 Transmission-frequency of Aspergillus fumigatus in cystic fibrosis patients
through coughing Tobias Engel, the Netherlands PP2.056 Experimental induction of tenuazonic acid toxicity in mice model Ankita Kumari, India
Poster Terminal 4Chair: Donna MacCallum, United Kingdom
PP2.089 Farnesol, tyrosol, and oxidative stress modulate the extracellular vesicle proteome and transcriptome in Candida albicans
Rosana Puccia, BrazilPP2.090 Inhibitory Effects of Lactobacillus Culture Supernatants on Candida
albicans Yuko Matsuda, JapanPP2.091 SCY-078: A first-in-class, orally-bioavailable, glucan synthase inhibitor has
broad spectrum activity against Candida, Aspergillus and Pneumocystis spp. Stephen Barat, USAPP2.092 Upregulation Gene Expression Levels of SAP 1-3 Vaginal Discharge
Candida albicans in Comparison to Culture of Candida albicans Isolates Seyedmahdi Hosseini, IranPP2.093 Virulence factors and susceptibility pattern of Candida albicans, Candida
tropicalis and Candida glabrata from clinical specimens, Mwanza-Tanzania Martha Mushi, TanzaniaPP2.094 Stress-contingent changes in Candida albicans SAPK pathway architecture
and regulation Alison Day, United KingdomPP2.095 Differential response of the bronchial epithelium and macrophages to
Aspergillus fumigatus allergens Sara Gago, United Kingdom
49
50
MONDAY 2 JULY 2018Poster Pitch session III12:15 - 13:15 hrs.Ruby Lounge
Poster Terminal 1 Chair: Andreas Groll, Germany
PP3.017 ZnO nanoparticles coated by Chitosan-Linoleic acid inhibit the Candida growth and Biofilm formation in vitro
Maryam Roudbary, IranPP3.018 AtrR, an essential regulator of azole resistance in Aspergillus fumigatus,
acts via the TR34 element in the cyp51A promoter Scott Moye-Rowley, USA PP3.019 Aspergillus fumigatus strains are adapted to the lung environment in a
case of chronic pulmonary aspergillosis Sara Gago, United Kingdom PP3.020 Antifungal Activity and Cytotoxic Effect of Echinophora Extract, Carvacrol
and Drug Caspofungin on Vaginal Candida albicans Infections on Cervical Cancer
Mohammad Yadegari, Iran PP3.021 Environmentally acquired mutations in Aspergillus fumigatus leading to
azole resistance: An Asian situation Yubhisha Dabas, India PP3.022 Concomitant isolation of Aspergillus species and Mycobacterium species
in respiratory tract of patients: an underestimated microbial interaction? Sarah Dellière, France
PP3.023 Posaconazole tablet therapeutic drug monitoring in patients with chronic pulmonary aspergillosis
Chris Kosmidis, United Kingdom PP3.024 Aspergillus fumigatus fumagillin as possible virulence factor Xabier Guruceaga, Spain
Poster Terminal 2 Chair: TBA
PP3.057 Multiplex qPCR for rapid identification of Candida auris, C. haemulonii, C. duobushaemulonii and C. pseudohaemulonii
Amir Arastehfar, the NetherlandsPP3.058 Comparative virulence of Candida auris with Candida haemulonii,
Candida glabrata and Candida albicans in a murine model Hamed Fakhim, Iran
PP2.172 Omics approaches give new insights into genome variability and evolution of basal human pathogens of the order Mucorales
Volker Schwartze, Germany PP2.173 Extracellular vesicles in the black yeast Exophiala dermatitidis: a first
characterization Barbara Blasi, ViennaPP2.174 Transposable elements contribute to fungal genes and impact fungal
lifestyle Anna Muszewska, Poland PP2.175 Combining a whole blood infection assay with biomathematical modeling
to classify innate immune function Ines Leonhardt, Germany PP2.176 Determining the chemical composition and antifungal activities of
aromatic water of Trachyspermum ammi Kamiar Zomorodian, Iran
Poster Terminal 8Chair: Ana Alastruey-Izquierdo, Spain
PP2.209 Bioluminescent Mucor circinelloides – a promising new tool to study mucormycosis and antifungal drug efficacy
Ulrike Binder, Austria PP2.210 Molecular diagnosis of invasive aspergillosis in a child with clinical
suspicion of mucormycosis Raquel Sabino, Portugal PP2.211 Antifungal susceptibility patterns of rare yeasts Antonio Pérez Hansen, Austria PP2.212 Impact of the use of biomarkers on early discontinuation of emirical
antifungal therapy in critically ill patients: a randomised controlled study Anahita Rouzé, France PP2.213 Nanoantimicrobials: A critique on Susceptibility, Mechanism of action and
Toxicity on opportunistic fungal pathogens Umamaheswari K., IndiaPP2.214 Repurposing FDA-approved Ebselen and Auranofin as anti-fungal drugs:
teaching old drugs new tricks Ashok Chaturvedi, USA PP2.215 Impedance-based de-replication of antifungal drug classes Jurgen Wuyts, Belgium PP2.216 New Antifungal Lipopeptides from Wild- type Bacillus subtilis RLID 12.1 Ramya Ramachandran, India
51
52
Poster Terminal 5 Chair: Vit Hubka, Czech Republic
PP3.137 In vitro inducing conditions to promote titan-like cells formation in C. neoformans Rocio García-Rodas, Spain PP3.138 Novel Dermatophytes from Indian soils Rahul Sharma, India PP3.139 In vitro and in vivo efficacy and toxicity of nonyl 3,4-dihydroxybenzoate, a
potent compound against dermatophytes biofilms Caroline Costa-Orlandi, Brazil PP3.140 New and emerging zoophilic dermatophytes in Europe Adela Cmoková, Czech RepublicPP3.141 Emergence of Trichophyton benhamiae in guinea pigs: a retrospective
study from the mycology laboratory of the veterinary college of Alfort Jacques Guillot, France PP3.142 Molecular epidemiology of Trichophyton mentagrophytes – a new
approach Silke Uhrlass, Germany PP3.143 A national survey on Tinea capitis in France: epidemiology and diagnostic
procedures Jean-Pierre Gangneux, France PP3.144 Place of Trichophyton soudanense in the Trichophyton rubrum complex: a
clinical isolates analysis Maud Gits-Muselli, France
Poster Terminal 6Chair: TBA
PP3.177 Conductivity: A novel approach for antifungal susceptibility testing Srivastava Neelabh, India PP3.178 Interactions with fungal cell wall polysaccharides determines the salt
tolerance of antifungal plant defensins Mark Bleackley, Australia PP3.179 The plant defensin HXP124 has the potential to be a new safe and
effective topical treatment for onychomycosis Nicole Van der Weerden, Australia PP3.180 The antifungal mechanism of action for plant defensins is defined via
treatment of a barcoded yeast deletion libraryf Kathy Parisi, Australia PP3.181 Fungal study of guano bat samples Cristine Goebel, Brazil
PP3.059 CoERG11 A395T mutation confers azole resistance in Candida orthopsilosis clinical isolates
Cosmeri Rizzato, Italy PP3.060 Severe recurrent vulvovaginal Candidiasis caused by mixed Candida
species Mohammad Effat, Egypt PP3.061 Optimization and application of fluorescent proteins in super-resolution
microscopy of Candida albicans Wouter Van Genechten, Belgium PP3.062 Ca37 monoclonal antibody inhibits Candida albicans growth in vitro and
in vivo Aitziber Antoran, Spain PP3.063 Activity of investigational tetrazole antifungals VT-1161 and VT-1598 against
a collection of clinical Candida tropicalis isolates with reduced fluconazole susceptibility
Jeffrey Rybak, USA
Poster Terminal 4 Chair: TBA
PP3.097 Development of echinocandin resistance after in vitro micafungin exposure in clinical isolates of Candida glabrata
Olga Rivero-Menendez, Spain PP3.098 Mechanisms of invisibility: 3D, real time and holographic imaging reveals
dynamics of Candida albicans evasion of host recognition June Bain, Spain PP3.099 Photodynamic inactivation can fight biofilms of Candida albicans strains
with constitutive efflux Helena Bujdáková, Slovak RepublicPP3.100 In vitro study of photodynamic inactivation against Fonsecaea monophora
and the application of ALA-APDT on refractory Chromoblastomycosis Liyan Xi, China PP3.101 Restoration Melanin of Fonseace monophora reduced Its Pathogenicity to
Galleria mellonella Yinghui Liu, China PP3.102 High-throughput RNA sequencing (RNA-seq) analysis of macrophages
infected with Fonsecaea monophora Junmin Zhang ChinaPP3.103 Fungal eye infections among ophthalmologic patients at ABSUTH, Aba,
Abia State, Nigeria Ada Ngwogu, Nigeria
53
54
MONDAY 2 JULY 2018Poster Pitch session IV18:00 - 19:00 hrs.Ruby Lounge
Poster Terminal 1 Chair: TBA
PP4.025 Molecular identification and antifungal susceptibility testing of fungal agents isolated from patients with idiopathic pulmonary fibrosis(IPF) in Tehran, Iran
Maryam Roudbary, Iran PP4.026 Isolation of Aspergillus species in respiratory specimens from adult
patients with acute exacerbation of non-cystic fibrosis bronchiectasis; Data from Pakistan
Kauser Jabeen, Pakistan PP4.027 Azole resistance in Aspergillus fumigatus. Frequency and distributions of
mutations in a tertiary center in the Netherlands Jochem Buil, the Netherlands PP4.028 Development and multicentre evaluation of a screening method for
echinocandin susceptibility testing of Aspergillus spp. Joseph Meletiadis, Greece PP4.029 Molecular identification and antifungal susceptibility patterns of invasive
Aspergillus species following CLSI and EUCAST guidelines Yubhisha Dabas, India PP4.030 The IL17RA and CARD10 genes are important in controlling Aspergillus
fumigatus colonisation of the lung in allergic bronchopulmonary aspergillosis
Sara Gago, United Kingdom PP4.032 Overexpression of cyp51A and cyp51b contribute to triazole resistance in
clinical isolates of Aspergillus fumigatus from the United States Jeffrey Rybak, USA
Poster Terminal 2Chair: Maiken Arendrup, Denmark
PP4.065 Modulation of Candida albicans infection by the non-selective muscarinic receptor agonist pilocarpine hydrochloride
Christopher Nile, United Kingdom PP4.066 Do Candida albicans biofilms contain persister cells? Iryna Denega, France
PP3.183 Impaired phagocytosis directs human monocyte activation in response to fungal derived ß-glucan particles
Jessica Quintin, Brazil PP3.184 Cutaneous infection caused by Fusarium lichenicola in a patient with
verrucous hyperplasia vermiculatum manifestation Sha Lu, China
Poster Terminal 8 Chair: Michaela Lackner, Austria
PP3.217 Genome mining and transcriptomic analysis of iron metabolism genes in Scedosporium apiospermum
Yohann Le Govic, France PP3.218 Production of Scedosporium boydii CatA1 and SodC recombinant
proteins: another step towards a standardized test for serodiagnosis of Scedosporium infections
Sara Mina, Lebanon PP3.219 Hybrid histidine kinase III: new therapeutic target for Scedosporium
apiospermum? Anaïs Hérivaux, France PP3.220 Lignin degradation pathway in Scedosporium species Wilfried Poirier, France
55
PP4.111 Molecular diagnostics of arthroconidial yeasts– frequent pulmonary opportunists
Engin Kaplan, Turkey PP4.112 Neglected diseases in Nigerians, diagnostics challenges: Invasive Fungal
Infections Rita Oladele, Nigeria
Poster Terminal 5Chair: Vishnu Chaturvedi, USA
PP4.145 Prevalence and virulence of the zoophilic dermatophyte Trichophyton benhamiae
Yvonne Gräser, Germany PP4.146 Epidemiology of dermatophytosis in the Caribbean Harish Gugnani, India PP4.148 Long-term practice of animal vaccination against dermatophytosis Marina Manoyan, Russia PP4.151 Application of real-time PCR assays for the diagnosis of histoplasmosis
using three molecular targets in human FFPE tissues and whole-blood Beatriz Lucia Gomez, Colombia PP4.152 Metagenomic analysis of environmental samples from mycetoma
endemic area in Sudan Sahar Bakhiet, Sudan
Poster Terminal 6 Chair: Anne van Diepingen, the Netherlands
PP4.185 Topical use of 1% luliconazole cream cured with Fusarium oxysporum infected refractory ulcers on an elderly patient’s leg and ankle
Xin Ran, China PP4.186 Primary cutaneous Fusarium solani infection in a hemodialysis patient Dongmei Shi, China PP4.187 Biological activity of lipids extracted from two isolates of Fusarium
oxysporum (environmental and clinical) in Galleria mellonella Pedronel Araque, ColombiaPP4.188 Diversity of clinically relevant Fusarium species complexes: preliminary
analysis of from an 11-yr prospective surveillance in France Dea Garcia-Hermoso, France PP4.189 Epidemiology and in vitro susceptibility of Fusarium species from human
infections in Germany – results of a retrospective multicenter study Axel Hamprecht, Germany PP4.190 Type 17 immunity controls Malassezia skin infection Florian Sparber, Switzerland
PP4.067 Identification of recessive lethal alleles in the Candida albicans genome: a constraint on loss-of-heterozygosity events in this species
Melanie Legrand, France PP4.068 Healthcare linen as a source of a mucormycosis case cluster that involved
different sites of infection and different Mucorales species Hong Nguyen, USA PP4.069 Genetically closely related azole-resistant Candida tropicalis in
environments can be a threat to healthcare Zi-Li Zhou, TaiwanPP4.070 Mapping the interaction of the Candida albicans multidrug resistance
ABC protein Cdr1 with pump inhibitor clorgyline that stimulates ATPase activity
Masakazu Niimi, Thailand PP4.071 Metabolic adaptation triggers Candida albicans biofilm phenotype Gordon Ramage, United Kingdom PP4.072 The use of long and short-read sequencing technology to elucidate
genomic variation and epidemiology of Candida glabrata in North America Rory Welsh, USA
Poster Terminal 4 Chair: Peter-Michael Rath, Germany
PP4.105 YEAST PANEL Multiplex PCR Assay for Identification of Invasive Yeast Pathogens: Novel Diagnostic Strategy, Useful for Developing Countries Amir Arastehfar, the Netherlands PP4.106 Increasing trend of mucormycosis mixed with other invasive mycoses from
a tertiary care centre in north India Jagdish Chander, India PP4.107 Invasive fungal diseases in patients with acute leukemia or allogeneic stem
cell transplantion recepients: A prospective multicenter observational study Gokhan Metan, Turkey PP4.108 A genetic and genomics approach identifies novel pathways of human
antifungal immune responses Vinod Kumar Magadi Gopalaiah, the Netherlands PP4.109 Epidemiology of fungaemia and fungal meningitis in Sweden: a nationwide
retrospective observational survey from sept 2015-aug 2016 Lena Klingspor, Sweden PP4.110 Comparative sequencing of ITS and D1/D2 domains of ribosomal DNA
for Molecular discrimination of fungal moulds Baskar Raju, India
5756
58
TUESDAY 3 JULY 2018Poster Pitch session V12:15 - 13:15 hrs.Ruby Lounge
Poster Terminal 1 Chair: Andreas Groll, Germany
PP1.005 Gene co-expression analysis identifies gene clusters associated with isotropic and polarized growth in Aspergillus fumigatus conidia
Tim Baltussen, the NetherlandsPP5.034 Composting as a resource for environmental azole resistance mutation in
Aspergillus fumigatus Bita Mousavi, France PP5.035 AfumID: An R Shiny application for Aspergillus fumigatus genotyping T.R. Sewell, United KingdomPP5.036 Environmental origin of clinical triazole resistance in Aspergillus fumigatus:
a longitudinal field study Sijmen Schoustra, the Netherlands PP5.037 Azole resistance of Aspergillus fumigatus in plant-decaying compost
model Jianhua Zhang, the NetherlandsPP5.038 Systematic interrogation of Aspergillus fumigatus cyp51A polymorphisms
for azole drug resistance Oliver Bader, GermanyPP5.039 Fungal contamination in horse stables and risk of equine aspergillosis:
results of a pilot study in France Jacques Guillot, FrancePP5.040 Chronic pulmonary aspergillosis in active pulmonary tuberculosis patients
in Jakarta, Indonesia Findra Setianingrum, United Kingdom
Poster Terminal 2 Chair: Maiken Arendrup, Denmark
PP5.073 The Kennedy pathway can increase the virulence of Candida albicans Todd Reynolds, USAPP5.074 Azole resistance and modulation of macrophage pro-inflammatory
response by Candida albicans MAM33 Neeraj Chauhan, USA PP5.075 Understanding the function of Pga15 family in Candida albicans
pathobiology Elham Khatrawi, United Kingdom
PP4.191 A rapid molecular assay for direct quantification of Malassezia pachydermatis in otic swabs
Gemma Castellá, Spain PP4.192 ‘PepBiotics’, novel antimicrobial peptides to fight fungal infections caused
by Aspergillus fumigatus and Malassezia furfur Hans De Cock, the Netherlands
59
PP5.120 Molecular characterization, virulence determinants and antifungal susceptibility testing of Trichosporon asahii isolates from Nepal
Niranjan Nayak, Nepal
Poster Terminal 5 Chair: Marcus Teixeira, USA
PP5.153 New insights on fibrogenesis and serum biomarkers for pulmonary fibrosis in paracoccidioidomycosis
James Venturini, Brazil PP5.154 Human and veterinary blastomycosis caused by Blastomyces helicus and
B. percursus identified among global fungal collections Ilan Schwartz, CanadaPP5.155 Talaromyces marneffei cell wall glucans: their role in recognition by host
cell and pathogenicity Aakash Gupta, Australia PP5.156 Comparative genomics of Rhinocladiella mackenziei A. Ahmed, Saudi ArabiaPP5.157 Evaluation of Quantitative Real-Time PCR and Platelia Galactomannan
Assay for Diagnosis of Disseminated Talaromyces marneffei Infection Cunwei Cao, China PP5.158 Susceptibility to hydrogen peroxide and molecular characterization of
catalase encoding genes in different Sporothrix species Cinzia Barresi, Italy PP5.159 Tuberculosis and histoplasmosis diagnosis among people living with HIV/
AIDS: the impact of using rapid diagnostics tests in Panama, 2017 Diego Caceres, USA PP5.160 Veterinary mycosis in a tropical country Alejandra Calderón-Hernández, Costa Rica
Poster Terminal 6 Chair: Teun Boekhout, the Netherlands
PP5.193 Mating type and population genomics in Malassezia Qi-Ming Wang, China PP5.194 Morbidity of fungal infections caused by Malassezia furfur in neonatal
intensive care units Tatiana Priputnevich, Russia PP5.195 Molecular identification and speciation of Malassezia and its susceptibility
pattern Romald Packia Nancy, India
PP5.076 Studying the role of CgMIP1 in the evolution of Candida glabrata during adaption to the human host
Sofia Siscar-Lewin, Germany PP5.077 Addressing the Most Neglected Diseases through an Open Research
Model: the Discovery of Fenarimols as Novel Drug Candidates for Eumycetoma
Wilson Lim, the Netherlands PP5.078 Establishing burn wound models for infection with Candida spp Christin Von Mueller, Germany PP5.079 T2Candida and blood culture results predict mortality among patients with
candidemia Cornelius Clancy, USA PP5.080 A Simple and Noninvasive Zebrafish Egg Infection Model for Studying
Pathogenic Yeasts Hsiu-Jung Lo, Taiwan
Poster Terminal 4 Chair: Peter-Michael Raht, Germany
PP5.113 Predictive value of a nasopharyngeal aspirate sample for diagnosis of pulmonary Pneumocystis in infants: A prospective autopsy study
Sergio Vargas, Chile PP5.114 Comparative analysis of yeast species identification using phenotypic
methods and real-time PCR Tatiana Priputnevich, Russia PP5.115 Comparing small and high volume sample fungal with routine culture for
improved yield of mold from sputa Joveria Farooqi, Pakistan PP5.116 Molecular diagnostic strategies in cancer patients with suspected
respiratory mold infections Volker Rickerts, Germany PP5.117 Agreement between phenotypic and molecular method for the
identification of filamentous molds: Experience from a routine diagnostic laboratory from Pakistan
Seema Irfan, Pakistan PP5.118 Molecular epidemiology, risk factor analysis and Comparison of diagnostic
methods for Rapid Diagnosis of Fungal Pneumonia in Critically ill Cirrhotics Pratibha Kale, India PP5.119 Pneumocystis jirovecii pneumonia in patients with hematological diseases
after hematopoietic stem cell transplantation and chemotherapy Yuliya Rogacheva, Russia
60 61
62
PP5.196 Activity of investigational tetrazole antifungals VT-1161 and VT-1598 against a collection of characterized fluconazole resistant Candida parapsilosis clinical isolates
Jeffrey Rybak, USAPP5.197 Polymerase chain reaction (PCR) diagnosis and identification of
mucormycosis in patients with suspected invasive fungal infection T. Shokohi, Iran PP5.198 Immunopathogenesis and virulence of invasive mucormycosis differs
considerably between mucormycete species Cornelia Speth, Austria PP5.199 Posaconazole prophylaxis in patients with acute myeloid leukemia: A real
life experience from a prospective multicenter observational study Gokhan Metan, Turkey PP5.200 Visceral mycoses in autopsied cases in Japan from 1989 to 2013:
increasing prevalence of cases with mucormycetes Yuhko Suzuki, Japan
63
SOCIAL PROGRAM
65
KIT Royal Tropical InstituteMauritskade 631092 AD Amsterdam
In 1926, after eleven years of building, the monumental building of KIT | Meetings & Events was completed. It is situated at Oosterpark and designed in neo-renaissance style by father and son Johannes Jacobus and Marie Adrianus van Nieukerken, upon instruction from the Colonial Institute that was founded in 1910 by private individuals and authorities. This is one of the first collaborations between
private individuals and the public sector. From here, research was conducted in the area of trade, anthropology and health care in the former Dutch colonies.The entire building was richly decorates with symbolic elements that refer to the various cultures of the world and the colonial history of the Netherlands. More than ten artists worked endlessly on sculptures, woodcarving and wrought iron to portray the trade, industry, foreign affairs, founders of the institute and the work done by it. The Marble Hall is the centre piece; the reception hall with its amazing twelve types of marble
SOCIAL PROGRAM
WELCOME RECEPTIONSaturday 30 June, 17:30 hrs.Welcome reception is offered to all registered delegates.The reception will take place on the exhibition and is free of charge.
YOUNG ISHAM EVENING Monday 2 July, 19:00 hrs. Following the scientific program on Monday 2 July, 19:00hrs. the Young ISHAM evening will be held at StrandZuid Amsterdam. This evening is only accessible for Young ISHAM members (and non-members) who are registered for this evening in advance. Not yet registered? Please check the registration desk for availability.Registered participants will receive an entry ticket for the evening in the delegate package.
Between RAI Amsterdam and the Beatrix Park (just a couple minutes walk from thecongress venue) you will find StrandZuid, a a chic inland beach complex. This evening will bring you an opportunity to network with colleagues while you enjoy a delicious barbecue and music.
StrandZuidEuropaplein 221078 GZ Amsterdam
CONGRESS DINNERTuesday 3 July, 18:00 hrs. The ISHAM Congress Dinner will be hosted in the KIT Royal Tropical Institute on Tuesday 3 July. All participants, who have pre-registered for the dinner, will receive an entry ticket in the delegate package. Not yet registered? Tickets are available at 95 EUR. Please check the registration desk for availability.
We gather at 18:00 hrs. at the main entrance of the RAI and will walk to the canal boats for a tour to the KIT Royal Tropical Institute. During the canal cruise we will explore the city while enjoying a snack and drinks.
64
REGISTRATION Registration fee onsiteISHAM Members EUR 625 Day-registration EUR 300Non – members EUR 655 Convener / speakers EUR 295YISHAM members /Students* EUR 345 Emerging Economy Rate** EUR 250
* Students are asked to provide a proof of status (student card). ** Emerging Economy Rate is applied to individuals (no group registrations) from low-income
and lower-middle-income economies according to the HINARI list (Group A and Group B). Hinari Core Offer includes two groups of countries, areas, or territories (Group A and Group B). Both groups can register for this special rate.
The registration fee includes: Admission to the meeting, program and digital abstract book, certificate of attendance, welcome ceremony, welcome reception and the lunches and coffee breaks.
CancellationCancellations and refund requests must be submitted in writing to the congress secretariat. Cancellations made before 1 May 2018 will be refunded less 30% to cover administration costs. After this date no refunds will be given. All refunds will be made after the congress.
Opening hours registration desk Saturday 30 June 08:00 - 19:00 hrs. Tuesday 3 July 08:30 - 18:00 hrs.Sunday 1 July 08:30 - 18:00 hrs. Wednesday 4 July 08:30 - 12:00 hrs. Monday 2 Juy 08:30 - 18:00 hrs.
NamebadgeAccess to all scientific events and to the exhibits is only possible with you personal name badge, which you will receive upon registration. All participants are requested to wear their name badges during the entire congress.
Public transport: 5-day passRegistered delegates who orderd a transportation pass during their registration, will receive a transportation pass when they pick up their name badge. The five-day transportation ticket provides you with unlimited travel on all GVB trams, buses, and metros, both day and night. The ticket becomes valid the first time you check in.
Social events Please see below an overview of the social events:
Welcome reception Saturday 30 June 17:30 - 19:00 hrs.Young ISHAM evening Monday 2 July 19:00 - 01:00 hrs.Congress dinner Tuesday 3 July 18:00 - 22:30 hrs.
66 67
GENERAL INFORMATION
68
InsuranceIn registering for ISHAM 2018, delegates agree that neither the organisation nor the congress agency Congress Care is responsible for individual medical, travel or personal insurance. Delegates are requested to make their own travel and health insurance. The organizers cannot assume liability for changes.
ISHAM Congress Mobile App This App can be downloaded from the App store (Apple) or Google Play Store (Android) at no costs. You can download the app in four simple steps:
1. Go to the Appstore or Google Playstore and search for ‘Congress Care’2. Install and open the app on your phone or tablet.3. Select the event ISHAM 2018 and click on ‘install’4. The app is now ready for use
In this App you will find a detailed overview of the scientific programm, abstracts, posters, exhibition and floor plan. For assistance and questions regarding the App, please see the staff at the registration desk.
Opening hours ExhibitionSaturday 30 June 12:30 - 19:00 hrs.Sunday 1 July 09:30 - 18:00 hrs.Monday 2 July 09:30 - 18:00 hrs.Tuesday 3 July 09:00 - 18:00 hrs.Wednesday 4 July 09:30 - 12:30 hrs.
ISHAM TwitterISHAM can be followed on Twitter, via @ISHAM_Mycology. If you would like to share your tweets with other delegates following ISHAM Congress 2018, please use #ISHAM2018.
WIFIWireless internet is available for all congress delegates.Network: CONGRESSWIFIPassword: congress@rai
SecretariatCongress CarePo Box 440NL-5201 AK, ’s-HertogenboschThe NetherlandsTel. +31 (0)73 690 14 [email protected]@congresscare.com
GENERAL INFORMATION
AccreditationThe 20th Congress of the International Society for Human and Animal Mycology, Amsterdam, Netherlands, 30/06/2018-04/07/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 20 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/ earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Please find below the maximum points of ECMEC®s per day:
Sunday 1 July - 6 pointsMonday 2 July - 6 pointsTuesday 3 July - 6 pointsWednesday 4 July - 2 points
Certificate of attendanceCertificates of attendance will be sent afterwards by email.
Congress languageThe official language of the congress will be English.No simultaneous translation will be available.
Congress venueRAI AmsterdamEntrance EEuropaplein 241078 GZ Amsterdam
69
70
EXHIBITORS SPONSORSSPONSORED SYMPOSIUM PFIZER
Date: Sunday 1 July, 2018Time: 12:30-13:30Location: Forum, RAI, the Netherlands
New opportunities for patient management in the fight against invasive mould disease (IMD)
12:30 Open and overview of IMD burden Prof. Peter Donnelly
12:40 Latest clinical data on management of invasive aspergillosis and mucormycosis Prof. Johan Maertens
13:00 Identifying suitable patients for new treatment strategies Prof. Oliver Cornely
13:20 Discussion and close All faculty
71
The ISHAM 2018 congress has been supported by a grant from Gilead Sciences Europe Ltd
72
FLOOR PLAN
Groundfloor
Firstfloor
MAIN ENTRANCEPARALLEL MEET INGROOMS
SPEAKERROOM
FORUM LOUNGE
PLENARY MEETING ROOM
FORUM
RUBY LOUNGE
E103
E104
E105
E106
E107
E108
E102Posters
RAI Congress Center, Amsterdam, The Netherlands
30 June - 4 July 2018
20th Congress of the International Society for Human and Animal Mycology (ISHAM)
www.isham2018.org
Program
www.isham2018.org
Regional scientific committeeAndreas GrollBart-Jan KullbergBas ZwaanEd KuijperFrank van de VeerdonkHan WöstenJohan MaertensJohan Mouton
Katrien LagrouMichael NeteaOliver CornelyPedro CrousPeter-Michael RathPieter Jan HaasTeun BoekhoutWendy van de Sande
Download the official ISHAM2018 APP
Do not forget to use #ISHAM2018 when posting photos and comments of the event on your social networks.
International scientific committeeAhmed Fahal Alexandro BonifazAna Alastruey-IzquierdoAndreas Groll, MunsterAndrew Ullman, WurzburgAnuradha ChowdharyArnaldo ColomboArturo CasadevallArunaloke Chakrabarti Ashraf IbrahimAxel BrakhageBernhard HubeBill SteinbachBirgit WillingerChristophe d’EnfertCornelia Lass-FloerlCornelius ClancyDarius Armstrong JonesDavid AndesDavid Denning David PerlinDimitrios KontoyiannisDonald SheppardDonna MacCallumElizabeth JohnsonEmanuel Roilides Eric DannaouiFlavio Queiros TellesGordon Brown
Hamid BadaliHan LiHideoki OgawaJean-Pierre Gangneux Jesus GuineaJoe HeitmanJoerg SteinmannJohan MaertensJosef Guarro, Josef MeletiadisKatrien LagrouLewis White, Livio PaganoLuis Ostrosky-Zeichner Mahmoud Ghannoum Maiken Arendrup Malcolm RichardsonManuel Cuenca, Marcus TeixeraMartin HoeniglMartin SchallerMatteo BasettiMatthew FisherMaurizio SanguinettiMichaela LacknerNathan Wiederhold Neil GowNelish GovenderNicolai Klimko
Nina Gunde-Cimerman Oliver CornelyOliver Kurzai Olivier LortholaryPatrice le PapePeter PappasPeter-Michael RathRetno WahyuningsihRoxana VitaleRuo-yu Li, Beijing, China Russel Edward Ruth AshbeeRyoji TsuboiSean Zhang,Sevtap Arikan Sharon Chen Shawn LockhartStephane BretagneStephane Ranque Thomas WalshTom Chiller, Tom PattersonTom RogersWanqing LiaoWei-da LiuWieland MeyerYee-Chun Chen
RAI Congress Center, Amsterdam, The Netherlands
30 June - 4 July 2018
20th Congress of the International Society for Human and Animal Mycology (ISHAM)
www.isham2018.org
Program
www.isham2018.org
Regional scientific committeeAndreas GrollBart-Jan KullbergBas ZwaanEd KuijperFrank van de VeerdonkHan WöstenJohan MaertensJohan Mouton
Katrien LagrouMichael NeteaOliver CornelyPedro CrousPeter-Michael RathPieter Jan HaasTeun BoekhoutWendy van de Sande
Download the official ISHAM2018 APP
Do not forget to use #ISHAM2018 when posting photos and comments of the event on your social networks.
International scientific committeeAhmed Fahal Alexandro BonifazAna Alastruey-IzquierdoAndreas Groll, MunsterAndrew Ullman, WurzburgAnuradha ChowdharyArnaldo ColomboArturo CasadevallArunaloke Chakrabarti Ashraf IbrahimAxel BrakhageBernhard HubeBill SteinbachBirgit WillingerChristophe d’EnfertCornelia Lass-FloerlCornelius ClancyDarius Armstrong JonesDavid AndesDavid Denning David PerlinDimitrios KontoyiannisDonald SheppardDonna MacCallumElizabeth JohnsonEmanuel Roilides Eric DannaouiFlavio Queiros TellesGordon Brown
Hamid BadaliHan LiHideoki OgawaJean-Pierre Gangneux Jesus GuineaJoe HeitmanJoerg SteinmannJohan MaertensJosef Guarro, Josef MeletiadisKatrien LagrouLewis White, Livio PaganoLuis Ostrosky-Zeichner Mahmoud Ghannoum Maiken Arendrup Malcolm RichardsonManuel Cuenca, Marcus TeixeraMartin HoeniglMartin SchallerMatteo BasettiMatthew FisherMaurizio SanguinettiMichaela LacknerNathan Wiederhold Neil GowNelish GovenderNicolai Klimko
Nina Gunde-Cimerman Oliver CornelyOliver Kurzai Olivier LortholaryPatrice le PapePeter PappasPeter-Michael RathRetno WahyuningsihRoxana VitaleRuo-yu Li, Beijing, China Russel Edward Ruth AshbeeRyoji TsuboiSean Zhang,Sevtap Arikan Sharon Chen Shawn LockhartStephane BretagneStephane Ranque Thomas WalshTom Chiller, Tom PattersonTom RogersWanqing LiaoWei-da LiuWieland MeyerYee-Chun Chen